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Quantitative analysis of DNA repair and p53 in individual human cells 
 
 
 
Abstract 
 
 
 
The goal of my research was to obtain a quantitative understanding of the mechanisms of 
DNA double-strand break (DSB) repair, and the activation of the tumor suppressor p53 in 
response to DSBs in human cells.   
 
In Chapter 2, we investigated how the kinetics of repair, and the balance between the 
alternate DSB repair pathways, nonhomologous end-joining (NHEJ) and homologous 
recombination (HR), change with cell cycle progression. We developed fluorescent 
reporters to quantify DSBs, HR and cell cycle phase in individual, living cells. We show 
that the rates of DSB repair depend on the cell cycle stage at the time of damage. We find 
that NHEJ is the dominant repair mechanism in G1 and in G2 cells even in the presence 
of a functional HR pathway. S and G2 cells use both NHEJ and HR, and higher use of 
HR strongly correlates with slower repair. Further, we demonstrate that the balance 
between NHEJ and HR changes gradually with cell cycle progression, with a maximal 
use of HR at the peak of active replication in mid-S. Our results establish that the 
presence of a sister chromatid does not affect the use of HR in human cells. 
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Chapter 3 examines the sensitivity of the p53 pathway to DNA DSBs. We combined our 
fluorescent reporter for DSBs with a fluorescent reporter for p53, to quantify the level of 
damage and p53 activation in single cells. We find that the probability of inducing a p53 
pulse increases linearly with the amount of damage. However, cancer cells do not have a 
distinct threshold of DSBs above which they uniformly induce p53 accumulation. We 
demonstrate that the decision to activate p53 is potentially controlled by cell-specific 
factors. Finally, we establish that the rates of DSB repair do not affect the decision to 
activate p53 or the dynamical properties of the p53 pulse.  
 
Collectively, this work emphasizes the importance of collecting quantitative dynamic 
information in single cells in order to gain a comprehensive understanding of how 
different DNA damage response pathways function in a coordinated manner to maintain 
genomic integrity.  
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Introduction to DNA double strand breaks 
 
Even under the best of circumstances, our genetic material constantly incurs damage 
from a variety of endogenously generated and external agents. Every human cell can 
accumulate up to 105 spontaneous DNA lesions per day (Hoeijmakers, 2009). Of the 
diverse lesions that can be generated on a DNA molecule, DNA double strand breaks 
(DSBs), formed when both phosphodiester strands are broken at sites usually less than 
ten nucleotides apart, are considered the most harmful. Unrepaired DSBs can result in 
cell death and mis-repair of DSBs can generate gross chromosomal alterations that 
compromise our genetic integrity. Failure to detect and address DSBs in a timely and 
accurate manner can lead to developmental defects, immunodeficiency, sterility, 
radiosensitivity and cancer predisposition (Jackson and Bartek, 2009).  
  
Inside cells, DNA is exposed to nucleases and metabolic products such as reactive 
oxygen and nitrogen species. These products introduce chemical modifications in the 
DNA, including modified bases and sugars, DNA intra- and inter-strand crosslinks, 
DNA-protein adducts, base-free sites and tandem lesions. DNA can also undergo 
spontaneous hydrolytic reactions and non-enzymatic methylations that generate 
thousands of base lesions per cell per day. DNA single strand breaks (SSBs) are 
commonly generated by free radical attack on DNA or when nucleases cut the 
phosphodiester backbone for the removal and repair of damaged bases. DSBs arise as an 
indirect consequence of two closely located SSBs, or when the DNA replication 
machinery attempts to replicate past SSBs and blocking lesions. SSBs and DSBs are also 
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occasionally introduced during DNA replication due to aborted topoisomerase I and 
topoisomerase II activity. Additionally, DSBs are directly generated as intermediates in 
developmentally regulated genome rearrangements such as meiotic recombination in 
germ cells (Richardson et al., 2004) and class switch recombination in maturing 
lymphocytes (Rooney et al., 2004). Other cellular processes including apoptotic DNA 
fragmentation (Rogakou et al., 2000), retroviral integration (Skalka and Katz, 2005), 
senescence (Sedelnikova et al., 2004) and dysfunctional telomeres (Hao et al., 2004) also 
provoke DSBs. Cellular stresses such as hyperosmotic stress (Kultz and Chakravarty, 
2001), hypoxia (Hammond et al., 2003) and heat shock (Kaneko et al., 2005; Takahashi 
et al., 2004; Takahashi et al., 2008) induce the classical indicators of DSBs, however the 
mechanisms by which they generate DNA breaks is not clear. 
 
Environmental agents such as ionizing radiation (IR), ultraviolet light (UV), and 
radiomimetic and chemotherapeutic drugs alter the chemical composition of the DNA 
backbone. IR, particularly X-rays, was the first environmental agent shown to be 
mutagenic in Drosophila melanogaster (Muller, 1927). We are constantly exposed to 
background levels of IR from cosmic radiation and from medical uses employing X-rays 
and radiography. IR can directly interact with and modify components of the DNA 
molecule. It also ionizes water molecules in the vicinity of DNA, producing free radicals 
that attack the hydrogen bonds in the DNA molecule. Drugs such as bleomycin and 
tirapazamine also act via the production of free radicals while etoposide and doxorubicin, 
which are commonly used in chemotherapy, are topoisomerase poisons that prevent 
topoisomerase II mediated DNA re-ligation. Other agents such as U.V. light which 
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produces SSBs, cyclobutane pyrimidine dimers and 6-4 photoproducts, crosslinking 
reagents such as cisplatin and actinomycin D, as well as alkylating agents such as N-
methyl N’-nitro-N-nitrosoguanidine and adozelesin generate DSBs by impeding DNA 
replication.  
 
The cellular response to DNA double strand breaks 
 
To avoid the deleterious consequences of DNA DSBs, eukaryotic cells have evolved a 
complex response that works swiftly to address these potentially cytotoxic lesions. In the 
DNA damage response (DDR), several signaling pathways co-ordinate the rapid 
detection of DNA lesions, with the activation of repair machinery and the establishment 
of cellular checkpoints that temporarily delay the cell cycle (Figure1.1, Ciccia and 
Elledge, 2010; Harper and Elledge, 2007). In certain contexts, the DDR also initiates 
apoptotic programs to eliminate severely damaged cells that fail to restore genomic 
integrity and re-establish cellular homeostasis. Various sensors (proteins that detect the 
lesion), mediators (proteins that amplify the damage signal) and effectors (proteins that 
function in repair and checkpoint initiation) are recruited to chromatin regions 
surrounding the break site (Zhou and Elledge, 2000). Some proteins, particularly those 
involved in checkpoint signaling, re-localize to the DSB transiently for activation and 
subsequently diffuse to transmit the damage signal throughout the nucleus (Bekker-
Jensen et al., 2006). Other proteins are recruited more stably and accumulate in large 
numbers to form macromolecular structures (called foci) around the break sites. Foci are 
microscopically discernible and serve as convenient markers for the location and number  
5	  
                                 
 
Figure 1.1: The general organization of the DNA damage response. 
DSBs are recognized by a sensor, which transmits the signal downstream to mediator proteins. 
Mediator proteins amplify the damage signal and initiate signal transduction cascades that activate 
effector molecules to induce repair and execute cell cycle arrest or cell death if the damage is 
irreparable.  
 
 
 
of DSBs. They are dynamic structures, in which numerous DDR factors assemble and 
disassemble in a precise spatio-temporal sequence that provides a kinetic choice of repair 
options (Polo and Jackson, 2011). During recruitment of DDR factors to the break site, 
large segments of chromatin are restructured in the vicinity of the DSB. This is mediated 
by a broad spectrum of post-translational modifications including phosphorylation, 
ubiquitination, sumoylation, acetylation and methylation. These modifications increase 
the accessibility of the damaged regions and allow the DDR proteins to be stably 
maintained at the break site (Ciccia and Elledge, 2010; Polo and Jackson, 2011).  
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The DDR is initiated when the primary sensor - the MRN (Mre11-Rad50-NBS1 in 
humans) complex, recognizes the DSB (Lavin, 2007). MRN then recruits ATM (ataxia-
telangiectasia mutated), a member of the phosphatidylinositol 3-kinase related kinase 
(PIKK) family of serine/threonine kinases, to the break. ATM is activated by 
autophosphorylation at the DSB (Bakkenist and Kastan, 2003; Lee and Paull, 2007). It 
then phosphorylates and activates several proteins involved in repair, signaling and 
checkpoint activation (Derheimer and Kastan, 2010; Lavin, 2008; Lavin and Kozlov, 
2007). The histone variant H2AX is a primary substrate of ATM; it is phosphorylated at 
serine 139 to generate a chromatin mark (γ-H2AX) that spreads to several megabases 
around the break (Rogakou et al., 1999; Rogakou et al., 1998; Stiff et al., 2004). γ-H2AX 
is subsequently bound by the mediator protein MDC1 (Lee et al., 2005; Lou et al., 2006; 
Stucki et al., 2005) which interacts with ATM and NBS1 (Chapman and Jackson, 2008; 
Lou et al., 2006; Melander et al., 2008; Spycher et al., 2008) to generate a positive 
feedback loop that amplifies the γ-H2AX signal and promotes additional recruitment of 
the interacting proteins (Lou et al., 2006). MDC1 itself is phosphorylated in an ATM-
dependent manner (Goldberg et al., 2003; Stewart et al., 2003), and this modification 
stimulates binding by the E3 ubiquitin ligase RNF8, which initiates a ubiquitination 
cascade that further modifies γ-H2AX (Huen et al., 2007; Kolas et al., 2007; Mailand et 
al., 2007). Once phosphorylated and ubiquitylated, H2AX facilitates the stable 
recruitment of mediator proteins such as 53BP1 and BRCA1 that amplify the damage 
signal and regulate the DSB repair pathways (Ciccia and Elledge, 2010; Polo and 
Jackson, 2011). In addition to enabling chromatin-modifying activities and mediator 
protein recruitment; activated ATM also phosphorylates and activates the checkpoint 
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protein Chk2 (checkpoint kinase 2) and the tumor suppressor p53 (Lavin and Kozlov, 
2007). Activation of these proteins elicits the rapid establishment of the G1/S and the 
G2/M cell cycle checkpoints and the execution of cellular programs that co-ordinate 
DNA repair with cell fate decisions.  
 
A fully active DDR sets into motion DNA repair activities that work to restore an intact 
DNA molecule. Eukaryotic cells utilize two main pathways for DSB repair – 
nonhomologous end-joining (NHEJ) and homologous recombination (HR). These 
pathways are described below.  
 
Double strand break repair by nonhomologous end-joining 
 
The nonhomologous end-joining pathway is abundantly used for repairing DSBs in 
somatic cells of higher eukaryotes including mammals. Although the NHEJ machinery 
has been identified in bacteria (Weller et al., 2002) and in lower eukaryotes such as the 
yeasts Saccharomyces cerevisiae and Saccharomyces pombe (Boulton and Jackson, 1996; 
Feldmann et al., 1996; Herrmann et al., 1998; Manolis et al., 2001; Ramos et al., 1998; 
Schar et al., 1997; Teo and Jackson, 1997; Wilson et al., 1999), it is only considered to be 
a backup system for repairing DSBs in these organisms. NHEJ joins the two ends of a 
DSB through a largely homology independent process that proceeds through three stages: 
detection of the DSB and tethering/protection of the DNA ends; DNA end processing to 
remove damaged or non-ligatable groups and DNA ligation (Hartlerode and Scully, 2009; 
Lees-Miller and Meek, 2003; Lieber et al., 2003; Mahaney et al., 2009). Depending on 
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the specific sequences and chemical modifications generated at the DSB, NHEJ may be 
precise or mutagenic. The core NHEJ factors comprise the Ku70-Ku80 heterodimer 
(collectively called Ku), DNA-PKcs, and the XRCC4-Ligase IV complex. 
 
NHEJ is initiated by the binding of Ku to both ends of the broken DNA molecule (Figure 
1.2). Both Ku70 and Ku80 subunits of the Ku heterodimer contribute to a central, toroidal 
DNA binding core that slides over dsDNA in a sequence independent manner (Walker et 
al., 2001). Association of Ku with DNA ends serves as a scaffold for the assembly of the 
NHEJ synapse, and the Ku-DNA complex recruits DNA-PKcs, a member of the PIKK 
family of protein kinases (Gottlieb and Jackson, 1993).  Ku then translocates inward on 
the DNA strand, allowing two DNA-PKcs molecules to contact DNA and interact across 
the DSB, forming a molecular bridge between the two DNA ends (DeFazio et al., 2002; 
Yoo and Dynan, 1999). The DNA-PKcs-Ku-DNA complex collectively forms the DNA-
PK holoenzyme, which serves to tether the ends of the DSB together and is thought to 
protect the DNA ends from nuclease attack. The association of DNA-PKcs with both 
DNA and Ku leads to the activation of its serine/threonine kinase activity (Yaneva et al., 
1997), promoting its autophosphorylation in trans across the DSB (Chan et al., 2002; 
Meek et al., 2007). This phosphorylation is essential for the release of the large DNA-
PKcs molecules from the DNA ends, which promotes access to the termini and sets the 
stage for re-ligation of the broken DNA molecule (Block et al., 2004; Ding et al., 2003; 
Weterings et al., 2003). Before ligation can take place effectively, non-complementary 
ends must be processed into 5'-phosphorylated, ligatable ends. Since DSBs can occur 
with a variety of different ends, a number of processing enzymes may be required to  
9	  
                               
 
Figure 1.2: The Nonhomologous end-joining pathway of DNA double-strand break repair. 
Induction of a DSB forms DNA ends that are bound by the Ku heterodimer. Bound Ku translocates 
inwards, allowing recruitment of DNA-PKcs to the extreme termini of the break. The end-processing 
enzyme Artemis is also recruited to the DSB in a complex with DNA-PKcs. Two DNA-PK molecules 
(DNA-PKcs bound to DNA-bound Ku) interact to tether the DSB ends together in synaptic complex. 
This triggers autophosphorylation of DNA-PKcs in trans, inducing a conformational change that 
causes a release of phosphorylated DNA-PKcs from the complex. It is unclear if Artemis is also 
released from the break site at the same time. Dissociation of DNA-PKcs from the DNA termini 
permits DNA end-processing enzymes such as polynucleotide kinase (PNK), DNA polymerases µ / λ 
and potentially others, to access the DNA ends and process them into compatible ends. The XRCC4-
Ligase IV (X4-L4) complex in conjunction with XLF subsequently ligates the compatible ends to 
yield an intact DNA molecule.  
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remove blocking end groups, fill in gaps, and/or remove damaged DNA or secondary 
structure elements surrounding the break. In case of single-stranded overhangs, DNA 
termini can be made ligatable by either filling in the missing nucleotides or by resection 
of the overhang. DNA polymerases µ and λ, terminal deoxyribonucleotidyltransferase, 
polynucleotide kinase, and several nucleases have been shown to play a role in this 
processing (Mahaney et al., 2009). Another key enzyme Artemis, is recruited to the DSB 
in a complex with DNA-PKcs and plays a role in removal of single-stranded overhangs 
and hairpin structures in the DNA (Mahaney et al., 2009). Since NHEJ occurs in the 
absence of a DNA template or extended regions of homology, processing of the DNA 
ends has the potential to result in an alteration of the nucleotide sequence, making NHEJ 
an inherently error-prone process. After correct processing, the two tethered DNA termini 
can finally be ligated. The Ligase IV-XRCC4 complex mediates ligation, possibly in 
conjunction with XLF/Cernunnos to restore an intact DNA molecule (Grawunder et al., 
1997; Gu et al., 2007).  
 
An alternative end-joining pathway that directly ligates DNA ends in the absence of core 
NHEJ factors has been recently identified, however, whether this pathway functions in 
normal cells or only when classical NHEJ is deficient is not clear.  This pathway, called 
alternative-NHEJ (alt-NHEJ) or microhomology mediated end-joining (MMEJ) involves 
distinct repair proteins including Poly-(ADP-ribose) polymerase-1 (PARP-1), DNA 
Ligase I/IIIα and XRCC1 and utilizes small sequence (5-25 nucleotide) microhomologies 
around the DSB to align broken strands of DNA (Hartlerode and Scully, 2009; McVey 
and Lee, 2008). After microhomology mediated annealing, the remaining non-
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complementary DNA segments are removed prior to ligation resulting in deletions 
flanking the original break. Alt-NHEJ is therefore frequently associated with large 
chromosomal abnormalities such as deletions, translocations, inversions and other 
complex rearrangements. 
 
Homology dependent pathways of double strand break repair  
 
Repair of DSBs by HR involves an exchange or transfer of information between the 
damaged DNA molecule and an identical sequence located on another intact homologous 
partner which can be a sister chromatid, homologous chromosome or direct repeat on the 
same or different chromosome. HR is the oldest pathway of DSB repair and is conserved 
from bacteria to humans. It is also the primary DSB repair pathway in prokaryotes and 
lower eukaryotes (Dudas and Chovanec, 2004). A large proportion of the genes essential 
for HR were initially identified in the budding yeast Saccharomyces cerevisiae by 
employing classical genetic methods – isolation of mutants based on their sensitivity to 
DNA damaging agents such as IR, followed by in-depth epistasis analyses and cloning of 
the corresponding genes by complementation of the mutant phenotype. These genes are 
collectively referred to as the Rad52 (Rad stands for radiation sensitivity) epistasis group. 
HR mutants are extremely radiosensitive and embryonic lethal in mice (Dudas and 
Chovanec, 2004). Mutations in several HR proteins have also been directly linked with 
cancer predisposition and human disease (Ciccia and Elledge, 2010; Heyer et al., 2010).  
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HR is initiated by nucleolytic resection of the 5’ DNA strands at the break site to generate 
single-stranded 3’ overhangs (Figure 1.3, Paques and Haber, 1999). This is a complex 
and critical step involving helicase and nuclease activity. In humans, the MRN complex 
and CtIP trim the DNA to an intermediate form, followed by more extensive trimming by 
the Exo1 and Dna2 nucleases (Mimitou and Symington, 2009). The BLM helicase 
provides the essential helicase activity and the recruitment of CtIP to the damaged sites in 
humans is facilitated by the action of the E3 ubiquitin ligase BRCA1 (Breast cancer 
susceptibility gene 1, (Huen et al., 2010). The 3’ single-stranded overhangs generated by 
resection are first coated by replication protein A (RPA) that eliminates secondary 
structures in these regions and protects them from degradation (Sung and Klein, 2006). 
RPA is subsequently replaced by multimers of the main recombinase enzyme Rad51 to 
form the recombinase filament. Loading Rad51 on the RPA coated single-stranded DNA 
(ssDNA) requires several accessory factors as RPA forms a kinetic barrier against Rad51 
filament assembly. In mammals, six mediator proteins that promote Rad51 loading on the 
ssDNA have been identified – five of these are Rad51 paralogs RAD51B, RAD51C, 
RAD51D, XRCC2, XRCC3 and the sixth protein is the human Breast Cancer 
susceptibility protein BRCA2 (Heyer et al., 2010; Jensen et al., 2010; Li and Heyer, 
2008). The exact function and interplay between the Rad51 paralogs in still poorly 
understood. BRCA2 promotes Rad51 filament nucleation at the ssDNA-dsDNA junction 
of the resected end (Jensen et al., 2010).  
 
Once formed, the Rad51 coated recombinase filament mediates the core reactions of HR, 
which are homology searching and invasion of homologous duplex DNA to form a D- 
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Figure 1.3: Pathways of homology-dependent DNA double-strand break repair. 
DSBs can be repaired by distinct homology-dependent repair pathways, such as break induced 
replication (BIR, a), double-strand break repair (DSBR, b), synthesis-dependent strand annealing 
(SDSA, c), and single-strand annealing (SSA, d). After DSB formation, the DNA ends are resected to 
yield 3′ single-strand DNA (ssDNA) overhangs, which become the substrate for the HR protein 
machinery to execute strand invasion of a partner chromosome. After a successful homology search, 
strand invasion occurs to form a nascent D-loop structure. DNA synthesis then ensues. (a) In the 
absence of a second DNA end, the D-loop may become a full-fledged replication fork that proceeds 
till the end of the DNA molecule. This generates half-crossover products. (b) In the DSBR pathway, 
the second DSB end is captured to form an intermediate that harbors two Holliday junctions (HJ)s, 
accompanied by gap-filling DNA synthesis and ligation. The resolution of HJs by a specialized 
endonuclease can result in either noncrossover (black triangles) or crossover products (gray triangles). 
(c) Alternately, in the SDSA pathway, the D-loop is unwound and the freed ssDNA strand anneals 
with the complementary ssDNA strand that is associated with the other DSB end. The reaction is 
completed by gap-filling DNA synthesis and ligation. Only noncrossover products are formed. (d) 
When end-resection uncovers tandem repeats, they anneal together directly without requiring strand-
invasion and D-loop formation. This is followed by trimming of the excess 3’ tails, gap filling and 
ligation to yield an intact DNA molecule that has one less repeat than the original sequence. 
Figure and legend adapted from (San Filippo et al., 2008). 
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loop intermediate (Heyer et al., 2010; West, 2003). Studies of the bacterial recombinase 
protein RecA suggest that the homology search probably occurs by random collisions 
between the nucleoprotein filament and duplex DNA where segments of the dsDNA are 
probed in an iterative fashion until homology is found (Bianco et al., 1998). When 
homology is established, the invading strand is used to prime repair synthesis by DNA 
polymerase (likely polymerase η in humans, McIlwraith et al., 2005). This leads to the 
formation of a D-loop intermediate. The Rad54 motor protein plays a key role in first 
stabilizing the Rad51 filament and enhancing D-loop formation and later for promoting 
the transition from DNA strand invasion to DNA synthesis by dissociating the Rad51 
multimers from heteroduplex DNA (San Filippo et al., 2008). After the D-loop 
intermediate is formed, repair can proceed via many sub-pathways (Heyer et al., 2010; 
San Filippo et al., 2008). In the double strand break repair (DSBR) pathway, the invading 
strand captures the second DSB end by annealing to the extended D-loop and leads to the 
formation of two crossed strands or Holliday junctions (Figure 1.3, pathway b). The 
Holliday junctions may move along the DNA by branch migration to extend or shrink the 
region of heteroduplex DNA and are eventually resolved to generate crossover or non-
crossover products. Alternately, the invading strand may be displaced to anneal with the 
second resected DSB end. This pathway of HR, called synthesis dependent strand 
annealing (SDSA), does not result in crossover products (Figure 1.3, pathway c). Under 
some circumstances, only one end of a DSB can be used for repair. This occurs when 
only one of the DSB ends shares homology with another region in the genome or when 
one end of a broken DNA molecule is lost. One-ended DSBs are also generated at 
collapsed replication forks in S phase and at telomeres that have lost their protective 
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telomeric repeats. In these cases, HR repair proceeds through the break-induced 
replication (BIR) pathway where the resected DSB end invades a homologous sequence 
and initiates unidirectional DNA synthesis from the site of strand invasion (Figure 1.3, 
pathway a). BIR usually proceeds for long distances, often covering the entire 
chromosome and may result in a large-scale loss of heterozygosity.   
 
The last sub-pathway of homology-dependent repair does not require Rad51 filament 
formation and functions independent of strand invasion, D-loop extension and Holliday 
junction resolution. This pathway, known as single-strand annealing (SSA) occurs when 
5’ resection of DSB ends uncovers direct repeats flanking the break site (Figure 1.3, 
pathway d). In such cases, complementary strands from each repeat sequence can anneal 
together to repair the break in a reaction catalyzed by the Rad52 protein. This results in 
the deletion of one of the repeats. Protruding single-stranded tails that are not involved in 
annealing may be further trimmed by nucleases and the resulting gaps or nicks are filled 
in by DNA synthesis and ligation. As approximately 50% of the mammalian genome 
comprises repeat sequences (Lander et al., 2001), DSB repair by SSA, may potentially be 
a frequent source of mutagenesis. 
 
Regulation of the DNA double strand break repair pathway choice 
 
NHEJ and HR are both critical for maintaining genomic integrity and the two pathways 
cooperate to enhance the overall efficiency of DNA repair. Mutants in either pathway 
show increased radiosensitivity, and single knockouts of multiple proteins functioning in 
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either pathway (for e.g., Rad51, BRCA1, BRCA2, and XRCC2 in HR and DNA ligase IV 
and XRCC4 in NHEJ) are embryonic lethal in mice (Pierce et al., 2001b). Additionally, a 
concurrent loss of a protein from each pathway generates a more severe phenotype than 
the knockout of a single pathway alone. For example, chicken cells mutated for Rad54 
and Ku70 or DNA-PKcs are acutely radiosensitive compared to single mutants 
(Fukushima et al., 2001; Takata et al., 1998) and embryonic fibroblasts deficient for both 
Rad54 and DNA ligase IV accrue high levels of spontaneous DNA damage and 
chromatid breaks (Mills et al., 2004). Similarly, mice with mutations in Rad54 and Ku80 
exhibit decreased survival, increased accumulation of unrepaired DSBs and extreme 
radiosensitivity, while single mutants are viable (Couedel et al., 2004). 
 
While both NHEJ and HR are crucial for DSB repair and survival, the two pathways are 
not always activated at the same time and are not completely redundant in the DSB 
substrates they repair. Several factors including the cell type and organism, nature of the 
lesion, the surrounding chromatin complexity and cell cycle phase regulate the activation 
of, and choice between pathways (Jeggo et al., 2011; Kass and Jasin, 2010; Shrivastav et 
al., 2008). Lower organisms such as bacteria and yeast rely heavily on HR, while NHEJ 
is the preferred pathway for repair in humans. Even within an organism, different tissues 
vary in their use of NHEJ and HR and the same tissue may employ different pathways 
depending on its developmental stage. This is particularly eminent in neuronal tissues, 
where developing neurons require functional HR in the early proliferative stages but 
switch to a greater use of NHEJ in the post-mitotic stages (Orii et al., 2006). Programmed 
DSBs are channeled into specific repair pathways in a regulated manner: DSBs generated 
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during V(D)J recombination in lymphocytes are repaired by NHEJ (Dudley et al., 2005) 
while DSBs generated during meiosis in eukaryotes are repaired exclusively by HR (Cole 
et al., 2010) .  
 
More generally, cell cycle is the primary determinant of pathway choice. NHEJ operates 
throughout the cell cycle while HR is restricted to the S/G2 phases (Rothkamm et al., 
2003). This restriction makes sense from the standpoint that the sister chromatid, which is 
the primary repair template, particularly in mammals, is not present in G1 cells. The 
earliest evidence of the differential usage of NHEJ and HR through the cell cycle was 
obtained from studies of mutant chicken DT40 cells. Cells deficient in NHEJ factors were 
found to be highly sensitive to IR in the G1 and early S phase of the cell cycle, whereas 
HR mutants were sensitive primarily in the S and G2 phases (Takata et al., 1998). This 
was further corroborated by the observation that mammalian cells deficient in NHEJ 
factors demonstrated reduced repair in all cell cycle stages, while HR deficient cells had a 
minor defect in G1, and a greater impairment in S/G2/M phases (Hinz et al., 2005; 
Rothkamm et al., 2003). Additionally, it was observed that DNA end-resection, 
accumulation of proteins in ssDNA compartments and Rad51 foci formation, which are 
key steps of the HR pathway, are temporally restricted to the S and G2 phases in yeast 
and in mammalian cells (Bekker-Jensen et al., 2006; Jazayeri et al., 2006; Lisby et al., 
2004; Tashiro et al., 2000). Recent work suggests that this restriction of HR to post-
replicative cell cycle phases is actively mediated by cylin dependent kinase (CDK) 
activity. Failure of G1 arrested yeast cells to initiate efficient end resection and load HR 
factors at an HO induced DSB locus correlates with low levels of active CDK1 (Aylon et 
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al., 2004). Consistent with this, inhibiting CDK1 activity in G2 cells also prevents end 
resection in this phase. Interestingly, in yeast, CDK1 activity is sufficient to initiate HR 
even in the absence of DNA replication, suggesting that the presence of replicated sister-
chromatids does not influence the use of HR in these cells (Aylon et al., 2004). It is 
presently unclear if this is also the case in mammalian cells.  
 
CDK1 controls HR by regulating a core protein of the DNA resection machinery - Sae2 
in Saccharomyces cerevisiae / CtIP in humans (Huertas et al., 2008; Huertas and Jackson, 
2009; Sartori et al., 2007). Cells expressing a non-phosphorylatable Sae2/CtIP protein 
demonstrate delayed HR; conversely, cells expressing constitutively phosphorylated 
Sae2/CtIP forms initiate end resection even in the absence of CDK activity and 
demonstrate accelerated HR in post-replicative cell cycle phases (Huertas et al., 2008; 
Huertas and Jackson, 2009). Phosphorylation of CtIP by CDK1 promotes its interaction 
with BRCA1 and facilitates its recruitment to break sites (Yu and Chen, 2004; Yun and 
Hiom, 2009). Additionally, CDK1 activity also regulates BRCA2-Rad51 interaction that 
may further control HR in mammalian cells (Esashi et al., 2005).  
 
In the S and G2 phases when both NHEJ and HR are licensed to operate, the two 
pathways likely contend for access to individual break sites. Indeed, cells lacking 
functional NHEJ proteins reveal a DSB repair bias in favor of HR while end-resection 
mutants show increased frequencies of NHEJ, suggesting that these pathways normally 
compete for DSBs (Delacote et al., 2002; Huertas et al., 2008; Lee et al., 1998; Pierce et 
al., 2001a; Yun and Hiom, 2009). When both NHEJ and HR are active, other factors such 
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as the nature and location of the break may bias the use of pathways. NHEJ can swiftly 
repair breaks that have low complexity and are predominantly localized in easily 
accessible euchromatic regions. However, repair may not be readily achieved when 
breaks have ‘dirty’, non-ligatable ends such as those generated by heavy ions and high 
LET radiation or when breaks are generated in compacted heterochromatic regions. In 
these cases, NHEJ is aborted when it fails to ensure rapid repair and the breaks are 
subsequently directed to the HR pathway (Jeggo et al., 2011; Shibata et al., 2011).  
Another instance where the nature of the break directs a preferential use of a specific 
repair pathway is the use of HR for restoring collapsed replication forks in S phase 
(Petermann and Helleday, 2010). DSBs arising during DNA replication may typically be 
one ended, and necessitate repair by HR as NHEJ requires two free DNA duplex ends for 
repair.  
 
Despite numerous mechanistic insights into the regulation of repair pathway choice, a 
clear picture of how individual cells balance NHEJ and HR with cell cycle progression is 
still lacking. With the current progress in live cell imaging techniques and single-cell 
approaches it is now feasible to capture the repair process over time in the same living 
cell. Such observations afford a more comprehensive understanding of the dynamics and 
interplay of different DSB repair pathways at different stages of repair, and in diverse 
cellular contexts. 
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The connection between DNA double strand breaks and the tumor suppressor p53 
 
A primary outcome of the DNA damage response is the activation of cellular checkpoint 
mechanisms that link DNA lesions with effectors of cell fate (Figure 1.1, Zhou and 
Elledge, 2000). The most notable cell fate regulator activated by this response is the 
transcription factor and tumor suppressor p53. p53 is induced by diverse stresses that 
impact on cellular homeostatic mechanisms that monitor and control the fidelity of DNA 
replication, chromosome segregation and cell division (Vogelstein et al., 2000). Active 
p53 can execute distinct cellular programs that effect transient cell cycle arrest and DNA 
repair or result in irreversible outcomes such as cellular senescence and apoptosis (Riley 
et al., 2008). These functions of the p53 pathway are critical to maintaining genomic 
integrity, limiting oncogene activation and preventing tumorigenesis, and their 
importance is underscored by the fact that almost all human cancers contain a 
dysfunctional p53 pathway that permits unregulated proliferation of severely damaged 
cells (Jin and Levine, 2001). Activation of p53 and its network of genes in response to 
cellular stress also sets into motion an elaborate network of autoregulatory positive and 
negative feedback loops that ensure a complete execution of the p53 program or lead to 
reversal if the stress stimulus has been adequately addressed (Harris and Levine, 2005).   
 
Under normal, unstressed conditions, p53 is kept at a low level, predominantly by its 
interaction with its negative regulator H/Mdm2 (human/mouse double minute 2) Mdm2 
is a E3 ubiquitin ligase that tags p53 for degradation by the 26s proteasome (Kruse and 
Gu, 2009; Wu et al., 1993). Mdm2 is also a target gene of p53, and any increase in p53 
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levels leads to an increased transcription and production of mdm2, which in turn serves to 
lower p53 levels. In response to DNA damage, both the level of p53 as well as its 
transcriptional activity rapidly increases. Every type of DNA lesion including SSBs, 
DSBs, alkylated and depurinated bases, DNA crosslinks, and alterations of the 
deoxyribose sugar moiety is reported to the p53 pathway (Giaccia and Kastan, 1998; 
Gudkov and Komarova, 2003; Oren, 2003). However, the behavior of p53 post DNA 
damage is perhaps best characterized in response to DNA DSBs. In the presence of 
DSBs, induction of p53 is achieved by activation of the upstream mediators ATM and 
Chk2 that introduce post-translational modifications, specifically phosphorylations, on 
p53 and Mdm2 (Figure 1.4a, Banin et al., 1998; Canman et al., 1998; Chehab et al., 1999; 
Khosravi et al., 1999; Maya et al., 2001). These modifications disrupt p53-Mdm2 
interaction and improve the stability of the p53 protein. Activated p53 exhibits a 
remarkable dynamic behavior, where the levels of p53 exhibit a series of undamped 
pulses in single cells (Lahav et al., 2004). p53 pulses have been observed in several 
transformed and non-transformed cells in culture (Hu et al., 2007; Lev Bar-Or et al., 
2000; Loewer et al., 2010), as well as in a live mouse model (Hamstra et al., 2006). These 
pulses are generated in an excitable manner where a transient damage signal suffices to 
elicit a full p53 response (Batchelor et al., 2008; Loewer et al., 2010). The shape of the 
pulses is regulated by a combination of two negative feedbacks - the negative feedback 
between p53 and Mdm2, and an additional negative feedback between p53 and its 
upstream modulators ATM and Chk2 (Batchelor et al., 2008). Active p53 transcribes a 
phosphatase WIP1 that abrogates ATM and Chk2 phosphorylation, in addition to 
dephosphorylating p53 and Mdm2 (Fiscella et al., 1997; Lu et al., 2007; Shreeram et al.,  
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Figure 1.4: The response of p53 to DNA double-strand breaks. 
(a) In response to DSBs ATM kinase is activated, and activates Chk2. Both of these kinases 
upregulate p53 by disrupting its interaction with one of its target genes, the E3 ubiquitin ligase Mdm2. 
p53 also upregulates the transcription of the phosphatase Wip1 which negatively feeds back on the 
entire circuit by dephosphorylating ATM, Chk2, p53 and Mdm2. Solid lines represent protein–protein 
interactions, dashed lines represent transcriptional activation. (b) Single cell measurements of p53 
levels show a series of undamped pulses with different cells showing different numbers of pulses to 
the same damage dose. Figure and legend adapted from (Batchelor et al., 2009) 
 
  
 
 
2006). This results in an oscillatory behavior of the ATM and Chk2 activities, which is 
transmitted downstream to p53 (Batchelor et al., 2008). Characterization of individual 
p53 pulses reveals that they have fixed amplitude and duration, which are independent of 
the damage dose (Lahav et al., 2004). However, the number of p53 pulses increases with 
greater amounts of damage. Interestingly, genetically identical cells exposed to the same 
DNA damage dose exhibit varying number of p53 pulses (Figure 1.4b). It is unknown 
whether these cell-to-cell differences in p53 behavior result from a differential sensitivity 
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of individual cells to the same damage stimulus or arise from differences in their p53 
and/or other cellular networks. A rigorous quantitative assessment of the relationship 
between DSBs and p53 activation in single cells will provide insights into the sensitivity 
of the p53 network and enable a detailed understanding of p53 activation in response to 
DNA damage. 
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This Work 
 
Chapter 2 (Published in Molecular Cell, 2012) 
In this chapter we examine the effect of cell cycle on the rates of DNA DSB repair and 
the balance between NHEJ and HR in asynchronous, individual, living cells. To quantify 
these events in living cells, we developed a clonal U2OS cell-line that stably expresses 
fluorescent-tagged Geminin, 53BP1 and Rad52 that serve as markers for cell cycle stage, 
total number of DSBs and HR respectively. Using long-term time-lapse microscopy, we 
first show that cells damaged in different cell cycle stages vary in their kinetics of repair. 
Surprisingly, we find that cells damaged within S phase also exhibit a large variation in 
their rates of repair with cells damaged at mid-S repairing the slowest amongst all cells. 
This suggests that in S phase, the kinetics of repair are determined by the exact cell cycle 
position at the time of damage.    
 
Next, we show that the levels of HR change gradually with cell cycle progression. HR is 
activated as cells undergo the G1/S transition, following which its levels increase and 
peak at mid-S and then gradually decline towards late-S and G2. High proportions of HR 
in mid-S correlate with slower repair and high levels of active DNA replication. HR does 
not capture all breaks in a cell, rather S and G2 cells utilize both NHEJ and HR for repair. 
Additionally, NHEJ is the predominant repair pathway in G2 cells even when HR is 
functional. Our results demonstrate that the choice of repair mechanism is continuously 
adjusted throughout the cell cycle and suggest that the extent of active replication, rather 
than the presence of a sister chromatid influences the balance between the two repair 
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pathways in human cells. This study emphasizes the importance of collecting quantitative 
dynamic information at a single cell resolution for understanding the complex regulation 
and interplay of the DNA repair pathways. 
 
Chapter 3  
In chapter 3, we investigate the quantitative relationship between DSBs and the activation 
of the tumor suppressor p53 in single cells. Previous studies have demonstrated that 
genetically identical cells exposed to the same damage stimulus are highly diverse in 
their p53 response, where some cells show no p53 pulse and others exhibit a varying 
number of pulses. We hypothesized that these differences potentially arise from cell-to-
cell heterogeneity in the number of DSBs and their rates of repair. p53 may only be 
activated above a threshold number of DSBs or in cells that have slower repair. To 
monitor the number of DNA DSBs, their repair, and p53 activation in individual cells, we 
combined the 53BP1 reporter developed in Chapter 2 with a fluorescent reporter for p53 
in a stable, clonal MCF7 breast carcinoma cell-line. We found that, in response to a 
uniform damage dose, individual cells indeed vary in their initial number of DSBs and 
their rates of repair. The probability of inducing a p53 pulse increases linearly with the 
number of DSBs. Surprisingly, we did not detect a clear threshold of DSBs, above which 
all cells unanimously initiate a p53 pulse immediately after damage. This suggests that 
other factors such as the rates of repair or the cell cycle phase might influence a cell’s 
decision to pulse after damage. It is also possible that p53 pulses are generated primarily 
in a stochastic manner.  
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We explored this possibility and found that the decision to pulse is not entirely stochastic, 
but is potentially affected by internal cellular factors. We investigated the rates of repair 
as a potential factor that affects this decision. We found that the induction of p53 is 
insensitive to the half-life of DSBs as demonstrated by a lack of correlation between the 
rates of repair and the probability of generating an initial p53 pulse. Additionally, the rate 
of repair also did not affect the amplitude and duration of the p53 pulse. To probe this 
further by generating a longer delay in DSB joining, we knocked down XRCC4, a key 
protein in the NHEJ repair pathway. Unexpectedly, a reduced expression of XRCC4 did 
not significantly decrease the rates of DSB repair in our system. However, reducing the 
efficiency of the NHEJ pathway remarkably increased the duration of the initial p53 
pulse. We are currently exploring other potential factors that affect the activation of p53 
in response to DNA DSBs. Such an assessment of factors that impact on p53 behavior 
will offer important insights into the sensitivity of the p53 network to DNA damage. 
 
Chapter 4 
 
In chapter 4, I summarize and discuss the key findings from chapters 2 and 3 in the 
broader perspective of genomic instability and cancer. I describe how several types of 
cancer rely on a reduced subset of repair proteins to survive DNA damage. A 
comprehensive understanding of the natural balance between different repair pathways, 
as well as their ability to compensate for each other in altered cellular contexts is 
essential to grasp the beginnings of genomic instability in cancer and also for designing 
more selective therapies. The work described in Chapter 2 presents a step forward in this 
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direction. Cancer cells also exhibit remarkable heterogeneity in their response to drug 
treatment, such that chemotherapy only achieves a fractional killing of tumor cells. While 
heterogeneity in a tumor may arise directly from genetic sources, it is possible that 
isogenic cells also vary in their sensitivity to a chemotherapeutic agent. We explore this 
possibility in Chapter 3, and provide a rigorous quantitative assessment of how p53, an 
effector of cell fate decisions, is activated in response to DNA damage. An advanced 
understanding of the factors that influence the induction of p53 to mediate cell death or 
survival will enable the identification of drug regimes and strategies that effect maximal 
cell killing in tumors.  
 
I conclude this chapter with a note on the power of live cell imaging and single cell 
analyses in probing the dynamic behavior of cellular signaling pathways; and discuss 
how these methods can be effectively applied towards answering other fundamental 
questions in the DNA repair field.  
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Abstract 
 
DNA double strand breaks are repaired by two main pathways: non-homologous end 
joining (NHEJ) and homologous recombination (HR). The choice between these 
pathways depends on cell cycle phase; however the continuous effect of cell cycle on the 
balance between them is still unclear. We used live cell imaging and fluorescent reporters 
for 53BP1, Rad52 and cell cycle to quantify the relative contribution of NHEJ and HR at 
different points of the cell cycle in single cells. We found that NHEJ is the dominant 
repair pathway in G1 and G2 even when both repair pathways are functional. The shift 
from NHEJ to HR is gradual, with the highest proportion of breaks repaired by HR in 
mid-S, where amount of DNA replication is highest. Higher proportions of HR also 
strongly correlate with slower rates of repair. Our study shows that the choice of repair 
mechanism is continuously adjusted throughout the cell cycle and suggests that the extent 
of active replication, rather than the presence of a sister chromatid influences the balance 
between the two repair pathways in human cells.  
 
Introduction 
 
DNA double strand breaks (DSBs) are potentially cytotoxic lesions generated during 
normal cell metabolism or by ionizing radiation and chemotherapeutic drugs. Their repair 
is critical for the successful maintenance and propagation of genetic information. In 
mammalian cells, two distinct pathways promote repair of DSBs, non-homologous end 
joining (NHEJ) and homologous recombination (HR). In NHEJ, the broken DNA ends 
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are aligned and ligated together without requiring long sequence complementarities 
(Lieber et al., 2003). HR requires an intact homologous sequence located on a sister 
chromatid, or elsewhere in the genome. It is initiated by resection of DNA at the break 
site to generate 3′ single-stranded DNA overhangs that invade the DNA double helix of 
the undamaged, homologous partner and copy information back to the break site (West, 
2003). Both NHEJ and HR are essential for genome maintenance, and defects in either 
pathway are linked to immunodeficiency, cancer predisposition and other diseases.  
 
A critical question is how the choice of DNA repair pathway is regulated. The current 
view is that cell cycle is the key regulatory factor that guides the decision between 
pathways (Shrivastav et al., 2008). NHEJ functions throughout the cell cycle, but is 
assumed to be most important in G0/G1 (Lieber et al., 2003). HR was suggested to be 
active only in the post-replicative stages of the cell cycle, S and G2, during which time 
the preferred homologous template – the sister chromatid - is available (Aylon et al., 
2004; Johnson and Jasin, 2000; Kadyk and Hartwell, 1992; West, 2003). This cell cycle 
dependent competency for HR was suggested to be regulated by the activity of cyclin 
dependent kinases (CDKs), which control DSB resection, a prerequisite for HR (Aylon et 
al., 2004; Huertas et al., 2008; Huertas and Jackson, 2009; Ira et al., 2004; Yun and 
Hiom, 2009). Interestingly, the physical presence of replicated DNA did not affect the 
choice of repair mechanism in yeast (Aylon et al., 2004). It is unclear whether this is also 
the case in mammalian cells. In addition, it is unclear how individual mammalian cells 
transition between the two mechanisms with cell cycle progression (Figure 2.1A), 
whether all breaks in a cell are repaired exclusively by one mechanism, and is the choice  
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Figure 2.1:  Experimental system for quantifying DSBs and cell cycle phase in single, living cells 
 
(A) Potential models of the transition between NHEJ and HR with cell cycle progression. The 
transition can be switch like (i) where cells completely shift to HR on entering S phase; or a more 
gradual change (ii) where cells utilize more HR with greater progress in S and G2 as the amount of 
replicated homologous substrate accrues. (B) Schematic drawing of the Geminin reporter. (C) Time 
lapse images of a freely cycling U2OS cell expressing the Geminin-CFP reporter. Images are overlays 
of the phase and CFP channels. (D) Quantification of the average nuclear Geminin-CFP intensity in a 
freely cycling cell over one cell division (indicated by the sharp drop in intensity). (E) Heat map of 
Geminin-CFP intensities in individual cells over time. Each horizontal line represents a single cell; 
blue represents low Geminin intensity; red represents high intensity. Cells were clustered according to 
their time of mitosis (tM, diagonal black line). Damage was applied at the 24h time point (tD). Cells at 
the top were in G2 when damage was applied, while cells in G1 are at the bottom. The red arrow 
indicates the trajectory of the cell shown in (C). (F) Schematic drawing of the 53BP1 reporter. (G) 
Cells expressing 53BP1-YFP were fixed and stained with anti γ-H2AX antibody after damage. The 
overlaid image shows co-localization between 53BP1 and γ-H2AX foci (see additional examples and 
quantification in Figure 2.2C-E). (H) Time-lapse images of a cell expressing 53BP1-YFP after 
damage. t' is the time elapsed from the initiation of DNA damage. Images are maximum projections of 
z-stacks through the nucleus (see Experimental Procedures) in the YFP channel. (I) Example of the 
automated segmentation for the enumeration of 53BP1-YFP foci in a cell. Image processing was 
performed using the Ensemble Thresher software package developed in our lab (see experimental 
procedures for algorithmic details). 	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of repair mechanism fixed at the time of damage or changed during the course of repair. 
Most of our knowledge about the relationship between cell cycle and the choice of 
repair pathway comes from measurements of fixed cells at specific times post 
damage. Such measurements allow estimation of cell cycle phase based on one fixed 
snapshot of a cell, followed by grouping of cells into three major phases G1, S and G2. 
However, each group includes cells that enter that phase at different times, potentially 
leading to large heterogeneity within each group. Direct connection between cell cycle 
phase and the choice of repair mechanism therefore requires quantification of these events 
over time in the same cell.  
 
Here, we use long-term, time-lapse microscopy and fluorescent reporters to measure 
DSBs, HR and cell cycle phase in asynchronous, individual living cells, and accurately 
determine the relationship between cell cycle state, choice of repair mechanism and 
kinetics of repair. Our results show that the choice of repair pathway is not fixed at the 
time of damage but rather is adjusted during the course of repair. NHEJ is the exclusive 
repair pathway in G1; however cells damaged in late G1 show low levels of HR as they 
progress into S. Once HR is activated, it does not capture all breaks, and the balance 
between NHEJ and HR changes gradually with cell cycle progression.  Specifically, S 
and G2 cells exhibit both HR and NHEJ with maximal use of HR in mid-S phase; during 
which time repair is the slowest and the amount of DNA replication is highest. Our data 
argue against the idea that the presence of replicated DNA determines the choice of 
repair, and instead suggest a direct link between the extent of active replication and HR.   
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Results 
 
1. Quantifying DSB repair and cell cycle in individual living cells 
We developed a fluorescent reporter system that allows quantification of cell cycle phase 
and DNA DSBs in individual living cells. To monitor cell cycle phase we expressed a 
CFP fusion of the N-terminal domain of Geminin (Figure 2.1B); which was previously 
shown to faithfully report APC inactivation (Sakaue-Sawano et al., 2008). Geminin-CFP 
slowly accumulates in cells post division; reaches maximal levels as cells enter mitosis, 
and then rapidly degrades during cytokinesis (Figure 2.1C, D). We imaged freely cycling 
cells for 24 hours prior to inducing DNA damage. During this time most cells divided at 
least once and their time of division was identified computationally based on the rapid 
drop in Geminin-CFP levels. Based on each cell's division time, we determined its cell 
cycle phase at the time of damage and the time that had passed since it entered that phase 
(see experimental procedures, Figure 2.1E, Figure 2.2A, B).  
 
We quantify DNA DSBs in single cells using 53BP1 fused to yellow fluorescent protein 
(YFP; Figure 2.1F). 53BP1 is a mediator protein in the DNA damage response. It 
localizes to DSB sites within minutes after damage and forms sub-nuclear compartments 
(foci) on chromatin regions adjacent to the break (Anderson et al., 2001; Bekker-Jensen 
et al., 2005; Schultz et al., 2000). As previously reported, we found that the tagged 
53BP1 protein forms distinct foci that co-localize with the	  canonical marker for DSBs, γ- 
H2AX (Figures 2.1G, 2.2C-E, Lobrich et al., 2010). Foci formed by DNA damage	  
response proteins such as 53BP1 and γ-H2AX provide an indirect measurement of DSBs 
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Figure 2.2: Characterization of the Geminin-CFP and 53BP1-YFP reporters 
 
(A) Average lengths of G1, S and G2 of U2OS cells as determined from their cell cycle distributions 
(See experimental procedures). (B) Time-lapse imaging setup to observe DNA repair and cell cycle 
phase in living cells. U2OS cells expressing 53BP1-YFP and Geminin-CFP are imaged undamaged for 
24h to determine their time of division. At 24h, the same cells are damaged with NCS (200 ng/mL) 
without disturbing the setup and imaging is continued for 20h post damage to measure the decay in 
53BP1-YFP foci numbers and obtain rates of repair in these cells. (C) U2OS cells expressing 53BP1-
YFP were fixed and stained with anti γ-H2AX antibody at the indicated times after damage (200 ng/mL 
NCS). The overlaid images show co-localization of the 53BP1-YFP and γ-H2AX foci. The zoomed 
overlay enlarges the foci enclosed by the white box 1h post damage. (D) The percentage of γ-H2AX 
foci that co-localize with 53BP1-YFP foci was calculated for each cell and are shown as probability 
histograms for a population of >200 cells. On average, 92.5% of γ-H2AX foci in a cell have a 
corresponding, co-localized 53BP1-YFP focus. (E) The percentage of 53BP1-YFP foci that co-localize 
with γ-H2AX foci (blue) and the percentage of γ-H2AX foci that co-localize with 53BP1-YFP foci 
(red) as a function of cell cycle phase. Each dot represents the average percent co-localization between 
the two proteins for cells binned according to their cell cycle stage. Cell cycle positions were 
determined from DNA content measured by DAPI staining. Co-localizations were measured for a 
population of > 200 cells. (F) Examples of G1 cells showing 53BP1-YFP localized to sites of mitotic 
chromosomal lesions before damage and at newly generated DSBs at 1h after damage (200 ng/mL 
NCS). (G) Distributions of the number of 53BP1-YFP foci at 1h (i) and at 24h post damage (200 
ng/mL NCS) in cells imaged either every hour for 24h (ii) or only at 24h (iii) post damage. (H) The 
proportion of cells in G1, S and G2 cell cycle phases in asynchronously growing populations of wild-
type U2OS cells and reporter cells engineered to express the 53BP1-YFP, Rad52-mCherry and 
Geminin-CFP reporters showing that expression of these reporters does not affect cell cycle 
distribution. Cell cycle distributions were obtained by flow cytometry using propidium iodide staining. 
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Figure 2.2 (continued) 
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in cells. For example, γ-H2AX and 53BP1 foci may be affected by factors that alter the 
signal persistence rather than the actual breaks. In addition, multiple breaks may cluster 
into a single focus. Despite these limitations, measurements of foci provide a sensitive, 
high-resolution quantification of breaks in individual cells and have been shown to 
faithfully reproduce results obtained from populations of fixed cells by more direct 
measurements of DNA breaks such as pulsed-field gel electrophoresis (Rothkamm and 
Lobrich, 2003). Our analysis showed that the number of 53BP1-YFP foci in a cell 
decreases with time (Figure 2.1H, 2.2C). Note that the number of 53BP1 foci we measure 
represents a balance between repair and generation of new breaks by internal cellular 
events such as replication. We were able to distinguish the large, high intensity 53BP1 
foci, which were recently shown to form at sites of mitotic chromosomal lesions in non-
damaged G1 cells (Lukas et al., 2011), from the numerous, smaller 53BP1 foci generated 
after damage induction by imaging the same cell before and after inducing damage (Fig. 
2.2F). We also confirmed that the decay in the number of foci post damage represents 
repair (and not decay of the fluorescent signal due to photo bleaching), by showing that 
the distribution of foci at 24 hours post damage is similar between cells that were imaged 
frequently (every hour) and cells that were imaged only at 24 hours post damage (Figure 
2.2G, p-value 0.99, Kolmogorov-Smirnov test).  We generated a double reporter cell line 
expressing both Geminin-CFP and 53BP1-YFP and confirmed that these reporters do not 
alter cell cycle distribution of asynchronously growing cells (Figure 2.1H).  
 
To induce DSBs, we used the radiomimetic drug neocarzinostatin (NCS). NCS creates a 
burst of DSBs and has been shown to act solely within five minutes following addition of 
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the drug to the cell culture medium (Shiloh et al., 1983). We chose to use NCS instead of 
irradiating cells because this allowed us to add the drug directly to cells on the 
microscope and follow the same cells before and after damage without disturbing the 
imaging setup and without a significant time delay in image acquisition. We verified that 
the kinetics of DSB repair post NCS treatment are similar to those obtained in irradiated 
cells (compare Figure 2.4A to Figure 2.3B). To minimize photo bleaching, we limited the 
imaging of cells to hourly intervals post NCS treatment. The mobility of foci and cells 
does not permit tracking individual foci between time points. Our measurements 
therefore provide the total numbers and intensity of foci in each cell over time.  
  
2. Cell cycle phase at the time of damage affects the rate of DSB repair 
We first asked if cells damaged in different stages of the cell cycle repair DSBs 
uniformly or if they vary in their kinetics of repair. Previous studies in fixed cells have 
suggested that DSBs are repaired with bi-phasic kinetics comprising a fast repair process 
(half-life of 0.5h - 2h) and a slower repair process (half-life of 12h - 24h). Since our 
measurements were collected at hourly intervals, the sampling of the early, rapid decay 
was limited to two data points. This resolution was insufficient to faithfully characterize 
and separate the fast repair kinetics from the overall repair trajectory, and we were able to 
observe clear, biphasic repair only in 12% of the cells. We therefore focused on the slow 
phase of repair and fit the enumerated 53BP1 foci from 2 hours post damage to an 
exponential decay until the net decay approached zero (Figure 2.3A). Our analysis 
revealed a large variation in the half-life of 53BP1 foci across cells with a peak around 4-
5 hours (Figure 2.3B). To test whether these variations relate to cell cycle phase, we  
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Figure	  2.3:	  Cell	  cycle	  position	  at	  the	  time	  of	  damage	  affects	  kinetics	  of	  DSB	  repair	  	  
	  
(A)	  Enumerated	  53BP1-­‐YFP	  foci	  (black	  dots)	  and	  the	  exponential	  fit	  to	  the	  raw	  data	  (red	  line)	  for	   the	   cell	   shown	   in	   Figure	   1H).	   (B)	   The	   distribution	   of	   half-­‐lives	   of	   53BP1-­‐YFP	   foci	   in	   an	  unsynchronized	  population	  (n>220	  cells)	  and	  as	  a	  function	  of	  cell	  cycle	  progression	  (C).	  In	  (C),	  the	   average	  half-­‐life	   of	   53BP1-­‐YFP	   foci	   is	   plotted	   for	   cells	   binned	  according	   to	   their	   cell	   cycle	  position	  at	  the	  time	  of	  damage.	  The	  plot	  was	  calculated	  with	  a	  sliding	  window	  of	  bin	  size	  W	  =	  2	  hours.	  Bars	  represent	  mean	  +	  SEM	  for	  a	  total	  population	  of	  >	  220	  cells.	  	  	  	  	  	  
	  	  
Figure	  2.4:	  Controls	  related	  to	  analysis	  of	  the	  rate	  of	  repair	  
	  (A)	   Distribution	   of	   the	   half-­‐lives	   of	   53BP1-­‐YFP	   foci	   across	   a	   population	   (~	   200	   cells)	   after	  damage	  with	   5Gy	   γ-­‐irradiation.	   (B)	   The	   decay	   constant	   obtained	   from	   exponential	   fits	   to	   the	  enumerated	  53BP1-­‐YFP	  foci	  is	  plotted	  against	  the	  initial	  number	  of	  53BP1-­‐YFP	  foci	  in	  each	  cell.	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binned cells according to their position in cell cycle at the time of damage and plotted the 
half-life of 53BP1 foci for cells in each bin (Figure 2.3C). Our results indicate a 
significant association (p<0.01, one-way ANOVA) between cell cycle phase and the rates 
of DSB repair.  We observed that cells damaged in G1 and G2 have comparable half-
lives of DSBs. In contrast, cells damaged in S phase show a large variation in their 
kinetics of repair. Cells at the G1/S transition attain the shortest half-lives of DSBs 
amongst all cells. Half-lives then gradually increase as cells enter S phase and peak in 
mid-S; followed by an acceleration of repair as presented by shorter half-lives in late-S 
and G2.  
 
The rapid kinetics of repair at the G1/S boundary may result from changes in chromatin 
structure in preparation for DNA replication, promoting accessibility of repair factors to 
break sites. Additionally, there may be increased availability of key substrates such as 
dNTPs, and DNA processing enzymes that allow rapid DNA repair during this time. The 
accelerated kinetics of repair towards the end of the cell cycle may be important to 
address DNA damage in a timely manner as cells progress towards mitosis.  
 
 
To ensure that the observed effect of cell cycle on repair kinetics is not merely due to 
differences in the initial number of DSBs, we plotted the rate of repair as a function of the 
initial number of breaks. We found no correlation between the initial number of breaks 
and the rate of repair (Figure 2.4B). At present, we cannot rule	  out the possibility that 
clustering of multiple repair sites into a single focus leads to the appearance of longer 
repair times.  
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Our results show that the dynamics of DSB repair differ significantly between cells in 
different cell cycle phases and even more strikingly, repair rates are not uniform for S 
phase cells, but rather are determined by the exact time a cell has spent in S phase at the 
time of damage.  
 
3. NHEJ is the dominant repair mechanism in both G1 and G2 cells  
Several factors, including the degree of chromatin compaction, level of CDK activity, 
and availability of nucleotide substrates could affect the rates of DSB repair through the 
cell cycle. Another potential factor is the balance between NHEJ and HR. It was recently 
suggested that NHEJ repairs breaks with faster kinetics than HR (Shibata et al., 2011). To 
quantify the extent of activation of the alternative repair pathways and the cell cycle 
dependent balance between them, we added a fluorescent reporter of Rad52 (Rad52-
mCherry) to cells expressing 53BP1-YFP and Geminin-CFP (Figure 2.5A). Rad52 is a 
recombinase mediator protein that forms foci at DSB sites that are committed to 
homology dependent repair (Essers et al., 2002). Evidence in mammalian cells suggests 
that Rad52 functions primarily in single strand annealing (Stark et al., 2004). An in vitro 
study of the human Rad52 protein indicates that it functions to catalyze the capture of the 
second DSB end prior to D-loop dissociation in canonical HR reactions (McIlwraith and 
West, 2008). More recently, it was demonstrated that Rad52 is synthetically lethal with 
the recombinase mediator BRCA2, and depletion of Rad52 in BRCA2 deficient cells 
impairs Rad51 foci formation, (Feng et al., 2011), suggesting that Rad52 functions in an 
independent, alternate pathway that supports Rad51 mediated classical HR repair.  
 
56	  
 
 
 
 
 
 
 
Figure 2.5: NHEJ dominates the repair of DSBs in G1 and G2 cells  
 
(A) Schematic drawing of the Rad52, 53BP1 and Geminin reporters for quantifying HR, total DSBs 
and cell cycle phase respectively in individual cells. (B) U2OS cells expressing the Rad52-mCherry 
reporter were fixed and stained with anti-BRCA1 antibody after damage. The overlaid image shows 
co-localization of the Rad52-mCherry and BRCA1 foci (see additional examples and quantification in 
Figure S3A-C). (C, E) Time-lapse images of U2OS cells expressing the reporters in (A) that were 
damaged in the G1 (C) or S (E) cell cycle phases. The 53BP1-YFP and Rad52-mCherry images are 
maximum projections of z-stacks through the nucleus (see Experimental Procedures). (D, F) 
Quantification of the number of 53BP1-YFP (green) and Rad52-mCherry (red) foci in the cells shown 
in (C) and (E) respectively. (G) Heat maps of 53BP1-YFP and Rad52-mCherry foci as a function of 
time after damage (x-axis) and cell cycle progression (y-axis). Cells were binned to 20% full interval 
on both axes. Blue represents low foci numbers and red represents high foci numbers in a range of 0-
120 (53BP1-YFP) or 0-100 (Rad52-mCherry) foci. Number of cells >140 (H) Heat map of Rad52-
mCherry foci zoomed in on cells damaged in G1. The gray bars on the right indicate the average EdU 
content (total nuclear intensity) for cells binned into three groups A, B and C (from early to late G1) 
based on their cell cycle stage at the time of damage. Number of cells >40.  
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Figure 2.5 (continued) 	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Homology dependent repair comprises many sub-pathways, which precludes the 
development of a single protein reporter that can capture all homology dependent events. 
We chose Rad52 to report on HR since it is not a key factor for mammalian HR (Rijkers 
et al., 1998; van Veelen et al., 2005) and we were concerned that high expression of core 
HR proteins (such as Rad51 and BRCA1) may disturb the natural balance between NHEJ 
and HR. However, one limitation of using Rad52 as an HR marker is that it may not 
accompany all HR reactions in mammalian cells. To evaluate if our Rad52 reporter 
captures all homology dependent repair events or a specific subset of HR reactions, we 
performed immunofluorescence based comparisons of Rad52-mCherry foci with 
BRCA1, a protein that functions in DNA resection, an early, essential step for all 
homology dependent events. (Figure 2.5B, Figure 2.6A). We found that 93.1% of Rad52-
mCherry foci in a cell had a corresponding, co-localized BRCA1 focus (Figure 2.6B). 
This may result from BRCA1 leaving the break before Rad52 is loaded. Interestingly, 
only 72% of the BRCA1 foci in a cell had a corresponding, co-localized Rad52-mCherry 
focus, indicating that 28% of breaks accompanied by BRCA1 are repaired by Rad52 
independent HR mechanisms. Thus the Rad52 reporter underrepresents the total number 
of foci repaired by homology dependent repair in our experimental system. However, this 
underrepresentation was found to be systematic and did not depend on cell cycle phase 
(Figure 2.6C). This demonstrates that the Rad52 reporter is reliable for studying the 
effect of cell cycle on all HR reactions that utilize BRCA1 mediated DNA resection. 
Lastly, since fluorescent reporters may provide a risk of altering the natural balance of 
proteins and cellular responses, we confirmed that insertion of the triple reporters does 
not alter the kinetics of repair (Figure 2.6D).  
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Figure 2.6: Characterization of the Rad52-mCherry reporter 
 
(A) U2OS cells expressing the Rad52-mCherry reporter were fixed and stained with anti BRCA1 
antibody after damage (200 ng/mL NCS). The overlaid images show co-localization of the Rad52-
mCherry and BRCA1 foci. Four cells with varying number of Rad52-mCherry foci are shown. The 
zoomed overlay enlarges the foci enclosed by the white box. (B) The percentage of Rad52-mCherry 
foci that co-localize with BRCA1 foci was calculated for each cell and are shown as probability 
histograms for a population of >200 cells. (C) The percentage of Rad52-mCherry foci that co-localize 
with BRCA1 foci (red) and the percentage of BRCA1 foci that co-localize with Rad52-mCherry foci 
(blue) as a function of cell cycle phase. Each dot represents the average percent co-localization 
between the two proteins for cells binned according to their cell cycle stage. Cell cycle positions were 
determined from DNA content measured by DAPI staining. Co-localizations were measured for a 
population of > 200 cells. (D) Kinetics of DSB repair in wild type U2OS cells and reporter cells 
engineered to express the 53BP1-YFP, Geminin-CFP and Rad52-mCherry reporters. Cells were 
damaged (200 ng/mL NCS), fixed and stained with anti γ-H2AX antibody at the indicated times post 
damage. Bars represent mean + SEM in a population of ~ 200 cells. (E) Cell cycle phase at the time of 
damage (y-axis) was determined as described in Figure 1. Cell cycle phase at maximal HR activation 
(x-axis) was determined by fixing cells at 11h post damage and measuring DNA content by DAPI. 
Bars represent mean + SEM for a population of  > 460 cells (F) The average half-life of Rad52-
mCherry foci in populations of cells damaged in S and G2 phases. Half-lives were calculated by 
fitting a single exponential decay to the enumerated Rad52-mCherry foci in individual cells. Bars 
represent mean + SEM for a population of > 60 cells in each group.  
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Figure 2.6 (continued) 	  	  
 
61	  
While all cells treated with NCS showed 53BP1 foci, formation of Rad52 foci was highly 
dependent on cell cycle phase, in agreement with previous studies in fixed cells (Bekker-
Jensen et al., 2006; Jazayeri et al., 2006; Lisby et al., 2004; Tashiro et al., 2000). S phase 
cells show higher numbers of Rad52 foci, while early/mid G1 cells show no Rad52 foci 
(Figure 2.5C-F). Interestingly, late G1 cells show low numbers of Rad52 foci at 12-16 
hours post damage (Figure 2.5G). To determine if this activation of HR results from G1 
cells progressing into S phase during the course of the repair, we exposed damaged G1 
cells to a 40 minute pulse of the thymine analogue EdU at the time of HR activation (13 
hours post damage) and analyzed their EdU content. We observed that early G1 cells that 
did not develop Rad52 foci also did not incorporate EdU (Figure 2.5H). Cells damaged in 
late G1 and at the G1/S transition incorporated higher amounts of EdU and developed 
Rad52 foci, indicating that they had progressed into S phase when HR was activated. 
This shows that the decision to activate HR in G1 cells is not fixed at the time of damage; 
cells in early G1 exclusively activate NHEJ for repair, however mid/late G1 cells first 
repair exclusively by NHEJ, but then progress into S phase and activate HR. Since NCS 
also leads to a small proportion of single strand breaks (SSBs, Shiloh et al., 1983), it is 
possible that as cells undergo the G1/S transition, SSBs may cause replication forks to 
collapse and generate one-ended DSBs that initiate HR repair.  
 
Based on current literature, the precise role of HR in G2 is somewhat controversial. On 
one hand, studies in HR deficient cells suggested HR as the dominant repair pathway in 
both S and G2 (Rothkamm et al., 2003; Takata et al., 1998). On the other hand, a more 
recent study shows that HR deficient cells can repair up to 85% of DSBs by NHEJ in G2 
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(Beucher et al., 2009). It is unclear if this reflects the behavior in wild-type cells or 
results from the ability of NHEJ to compensate for the absence of functional HR. Our 
system allowed us to determine the contribution of HR and NHEJ when both mechanisms 
are intact in wild-type cells. We found that cells damaged in G2 show low levels of HR, 
comparable to the levels seen in late G1 cells (Figure 2.5G). However this activation was 
much earlier (4h post damage in G2 cells compared to 12h in late G1 cells). Late G2 cells 
show very little or no induction of HR (Figure 2.5G). Importantly, G2 cells that divided 
after damage were eliminated from this analysis to ensure that the predominant NHEJ 
observed in this phase did not result from G2 cells progressing into G1 phase during the 
course of repair. Thus NHEJ is the dominant repair mechanism in both G1 and G2 cells 
even in the presence of a functional HR pathway.  
 
4. The balance between HR and NHEJ changes gradually with highest activation of HR 
in mid-S  
What fraction of DSBs is repaired by HR in S and G2 cells? To answer this we divided 
the number of Rad52 foci by the number of 53BP1 foci induced post damage (Figure 
2.7A). We observed that the proportion of HR gradually increases as cells progress from 
early S towards mid-S phase, followed by a decrease as cells progress to late-S and G2 
(Figure 2.7A). The same pattern was observed when the maximum proportion of HR in 
individual cells (calculated as the ratio between the maximum number of Rad52 foci to 
the total number of 53BP1 foci induced post damage), and the rates of Rad52 foci 
accumulation were plotted against cell cycle position (Figure 2.7B, C). Our data 
demonstrate that cells do not show an immediate and complete activation of HR on 
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Figure 2.7: Contribution of HR to DSB repair changes gradually with cell cycle progression and 
is highest in mid-S. 
 
(A) Heat map showing the proportion of DSBs channeled to the HR repair pathway over time post 
damage, calculated as the ratio between Rad52-mCherry foci to 53BP1-YFP foci. The ratio is shown 
as a function of the time elapsed from the induction of DSBs and cell cycle progression (indicated by 
the reference bar on the left). Cells were binned to 20% full interval on both axes. Blue represents low 
ratios and red indicates a higher proportion of HR. (B) The maximum proportion of HR in individual 
cells post damage is plotted against their cell cycle progression at the time of damage indicated by the 
reference bar on top. The median (black line), 25th and 75th percentile (dashed blue lines) of the 
population (n> 220 cells) are shown. (C) The rate at which Rad52-mCherry foci accumulate in 
individual cells post damage is plotted against their cell cycle progression at the time of damage. The 
median (black line), 25th and 75th percentile (dashed blue lines) of the population (n> 220 cells) are 
shown. (D) The rate of repair as a function of HR usage is plotted for cells binned according to their 
maximum Rad52-mcherry/53BP1-YFP foci ratio. Cells are binned according to a bin size of 0.03. 
Bars represent mean + SEM. Population of n>220 cells. (E, F) The amount of DNA replication as a 
function of S phase progression was measured by pulse labeling cells with EdU. Levels of EdU 
fluorescence are shown as a function of the DAPI fluorescence (E) for a non-synchronized population 
of cells. The level of DNA replication is quantified as the average EdU intensity per cell. To avoid 
bias from non-replicating cells, (F) was calculated from cells in the window shown in (E). (G) A new 
model for the transition between NHEJ and HR with cell cycle progression. Cells in G1 repair DSBs 
exclusively by NHEJ. Cells then increase their use of HR gradually as they progress from G1 to early 
S. Following a peak in mid-S, HR decreases gradually as cells move towards late S and G2, with late 
G2 cells repairing DSBs almost entirely by NHEJ. 
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Figure 2.7 (continued) 	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entering S phase. Instead, the level of HR increases gradually as cells progress from early 
to mid-S phase, followed by a gradual decrease when they progress to late-S and G2. We 
confirmed that the relative position of cells in S (early, mid, late) at the time of damage 
had not changed when they showed maximal activation of HR (11h post damage; Figure 
2.6E).  
 
The observation that mid-S phase cells attain the greatest proportions of HR (Figure 
2.7A, B) and exhibit the longest half-lives of DSBs (Figure 2.3C) suggests a potential 
correlation between the choice of repair pathway and the kinetics of repair. To investigate 
this further, we plotted the average decay constant obtained from exponential fits to the 
enumerated 53BP1-YFP foci for cells binned according to their proportions of HR post 
damage (Figure 2.7D). Indeed, a strong correlation was observed; the rates of repair 
declined with increasing contribution of HR to total DSB repair, supporting the idea that 
HR mediated DSB joining proceeds at a slower rate than NHEJ mediated repair. We also 
calculated the half-lives of Rad52 foci in cells damaged in S and G2, and found no 
significant difference (Figure 2.6F, p-value 0.2379, t-test), suggesting that the 5 – 10 hour 
variation in the half-life of DSBs observed between S and G2 results mainly from the 
choice of repair mechanism and not from differences in the kinetics of HR. Interestingly, 
there were several regimes in which an increase in HR did not produce a proportional 
change in repair rates (Figure 2.7D), supporting that, in addition to the extent of HR, 
other factors such as chromatin compaction and cyclin-CDK activity affect the kinetics of 
DSB repair.  
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5. Increased levels of HR in mid-S correlate with high levels of DNA replication 
When damaged cells replicate their DNA, SSBs and blocking lesions on the DNA may 
cause active replication forks to stall and collapse, resulting in one-ended DSBs. One-
ended DSBs breaks are repaired exclusively by HR (Helleday et al., 2007), as NHEJ 
requires two free DNA duplex ends for repair. The proportion of HR in S phase therefore, 
might depend on the level of active DNA replication. DNA does not replicate uniformly 
throughout S phase, rather different regions of the genome are replicated at distinct rates 
and times during S phase. In yeast, the highest replication origin firings occur near mid-S 
(Raghuraman et al., 2001). Even though replication timing is less well characterized in 
human cells, studies indicate that replication rates are highest around mid-S (Woodfine et 
al., 2004). To measure the level of DNA replication, we exposed an asynchronously 
growing population to a 20 minute pulse of EdU and quantified its content by flow 
cytometry. Within such a short time interval, the number of cells entering or exiting S 
phase is negligible and EdU fluorescence per cell is indicative mainly of level of EdU 
incorporation (i.e. amount of DNA replication). We found that cells in mid-S amassed the 
highest quantities of EdU (Figure 2.7E, F). This indicates that DNA replication was 
greatest in mid-S, correlating with the high proportions of HR observed during this time. 
This suggests that in mammalian cells, HR is most important for repair of DSBs created 
during active DNA replication.  
 
 
 
67	  
Discussion 
 
With recent advances in imaging techniques and single cell analyses, it has become clear 
that variability in internal states leads to remarkable heterogeneity in the behavior of 
isogenic cells exposed to a uniform stimulus (Snijder and Pelkmans, 2011). Studying how 
basal states affect individual cellular behavior is crucial for our ability to understand and 
predict cellular responses and for developing efficient drugs. In this study, we used 
fluorescent reporters for 53BP1, Geminin and Rad52 to assess how variations in cell 
cycle state impact the kinetics of DSB repair and the balance between alternate repair 
pathways in individual cells. Although an analysis of the rates of repair has been 
previously undertaken in populations of fixed cells (Shibata et al., 2011), our live cell 
system allowed us to develop a more comprehensive picture of how the kinetics of repair 
vary throughout the cell cycle and within each phase. We show that not only do the rates 
of repair differ between cells damaged in different cell cycle phases, but individual cells 
damaged in the same phase also vary significantly in the kinetics of repair. This 
heterogeneity is most pronounced for S phase cells; cells damaged closer to the G1/S 
transition attain the highest rates of repair amongst all cells, following which the rates 
decrease as cells progress to mid-S and then increase towards late S and G2. Based on 
these findings, we argue that the rates of DSB repair are fine tuned according to the exact 
time each cell has spent in a phase.  
 
Next, we show that the rate of repair strongly correlates with the contribution of HR to 
DSB repair, which also varies continuously with cell cycle progression. HR is absent in 
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cells damaged in early G1, following which it increases gradually and peaks at mid-S 
then declines towards late S and G2 (Fig. 2.7G). This shows that cells do not initiate a 
maximal use of HR immediately on entering S phase, nor do they show maximal HR at 
the end of S and in G2 when replication is complete. Our data therefore do not favor the 
idea that the presence of sister chromatids control the level of HR in the post replicative 
phases in mammalian cells.  
 
Our analysis also provided a measure of the variation between cells. We found that the 
proportion and rates of active HR vary widely even between individual cells damaged at 
the exact cell cycle position. For example, the proportion of breaks repaired by HR in 
cells at the G1/S transition (~ 8 h post division) vary from approximately 20% to 65% 
(Figure 2.7B). This suggests that the choice between NHEJ and HR is influenced by 
additional factors such as the nature of the break (one-ended or two-ended); chromatin 
complexity; or dose of DNA damage (Beucher et al., 2009; Shibata et al., 2011). 
 
One explanation for the high proportions of HR observed in mid-S is that NHEJ is unable 
to compete with HR for break sites during this phase. It is known that HR plays an 
exclusive role in the repair of one-ended DSBs that arise when replication forks stall at 
nicks in the DNA template and collapse in S phase (Helleday et al., 2007). When cells are 
damaged during peak DNA replication, nicks created on the DNA template may cause 
collapse of several active forks and create substrate that can only be addressed by HR 
mediated repair. We observe that in our cells; the highest amount of DNA replication 
occurs in mid-S, correlating well with increased proportions of HR observed during this 
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time. It is further tempting to speculate that a close association between replication 
machinery and HR factors leads to the gradual transition between NHEJ and HR as cells 
enter or exit S phase. The interaction of CtIP, a protein essential for DNA resection in the 
HR pathway, with PCNA, provides some evidence for this hypothesis (Gu and Chen, 
2009). G2 cells demonstrate a reduced efficiency of DNA resection compared to S phase 
cells that may further allow an increased channeling of DSBs into NHEJ as cells progress 
into G2 (Zierhut and Diffley, 2008). Additionally, while both cyclins A and B can 
activate the resection machinery, differences in their individual efficiencies could lead to 
a decline in HR with a gradual decrease in cyclin A activity as cells progress towards 
mitosis. Future studies employing conditional replication defective cell lines and 
perturbations that uncouple DNA replication from cyclin activity will help consolidate 
the relationship between active DNA replication, cyclin levels and HR repair.  
 
In this study we used U2OS cells, which lack a stable G1/S checkpoint. This allows cells 
damaged in G1 to progress into S phase and activate HR during the course of repair 
(Figure 2.5H). As in the case of U2OS, many cancers arise due to mutations in key 
regulators of the G1/S checkpoint and hence understanding how cells with disabled 
checkpoints repair DNA damage in response to chemotherapy is of clinical relevance. In 
addition, recent work has uncovered substantial limitations to the G1/S checkpoint even 
in damaged normal cells (Deckbar et al., 2010). First, the G1/S checkpoint is not fully 
initiated until several hours post damage, during which time many G1 cells enter S phase 
with unrepaired breaks. Second, at high doses of damage most cells undergo a permanent 
G1/S arrest, but a small fraction of cells escape arrest and enter S phase with DSBs. It 
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would be important to determine the choice and kinetics of repair in additional cancer and 
primary cells.  
 
The quantitative analysis presented here was made possible due to the use of fluorescent 
reporters in live cells. Previous studies that have used similar approaches provided 
important insights about the complex mechanisms that function to preserve genomic 
integrity in response to DNA damage. For example, fluorescent tagged 53BP1, Mdc1 and 
NBS1 provided a detailed understanding of the spatiotemporal sequence of events 
initiated on DSB generation and the causal relationship between them (Bekker-Jensen et 
al., 2005; Lukas et al., 2004).  In addition, using fluorescent H2B and probes that bind to 
an ISce1 induced break led to the discovery that free DNA ends at DSB sites have limited 
local movement and that damaged chromatin does not undergo large-scale movements 
(Kruhlak et al., 2006; Soutoglou et al., 2007). Therefore, fluorescent reporters that bind 
DSBs present a powerful tool for dissecting signaling kinetics and cellular decisions in 
individual cells.  
  
Ultimately, measurements using DNA damage and repair reporters in live cells will 
enable us to address additional long-standing, fundamental questions in this field. For 
example, reporters for NHEJ and HR in altered cellular states can teach us about their 
ability to compensate for each other under selective drug action. Reporters for the 
different sub-pathways of homology dependent repair can provide insights into their 
interplay and balance at different stages of repair. Such reporters can also help determine 
the timing at which commitment to a specific repair pathway occurs and the factors 
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leading to these decisions. Live cell reporters also enable the observation of time 
separated events in the same cells such as repair, cell cycle checkpoints and activation of 
tumor suppressor proteins. Such analyses in cellular backgrounds where key DNA 
response proteins are mutated have the promise of providing a comprehensive 
understanding of how specific mutations or polymorphisms lead to carcinogenesis. 
 
Experimental procedures 
 
Cell culture 
U2OS cells were grown in McCoy′s 5A medium supplemented with 10% fetal calf 
serum, 100 U/mL penicillin, 100 µg/mL streptomycin and 250 ng/mL fungizone (Gemini 
Bio-Products). When required, the medium was supplemented with selective antibiotics 
(400 µg/mL G418, 5 µg/mL blasticidin, 50 µg/mL hygromycin). When indicated, 
medium was replaced with fresh medium supplemented with 200 ng/mL 
Neocarzinostatin (National Cancer Institute) during experiments. Cell cycle distributions 
were analyzed by flow cytometry using propidium iodide or DAPI staining as indicated. 
DNA replication was measured by incorporation of EdU using the Click-iT EdU kit 
(Invitrogen). 	  
Cell Line Construction 
The original pCMV-EGFP-53BP1 construct was kindly provided by Prof. Yasuhisa 
Adachi (Jullien et al., 2002). We generated our pEF1a-EYFP-53BP1 plasmid by 
replacing GFP with YFP and combining this fluorescent protein-cDNA fragment with the 
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EF1a promoter in a vector harboring a neomycin resistance cassette using standard 
molecular biology techniques. This plasmid was stably transfected into U2OS cells using 
FuGENE6 (Roche), which were maintained in selective media and sorted into single cells 
using fluorescence activated cell sorting to generate a clonal population.  
 
Our pEF1a-mCherry-Rad52 plasmid was generated similarly from the original pCMV-
EGFP-Rad52 construct kindly provided by Prof. Roland Kanaar (Essers et al., 2002). The 
GFP tag was replaced with mCherry and the fluorescent protein-cDNA fragment was 
combined with the EF1a promoter in a vector harboring a blasticidin resistance cassette. 
Stable, clonal cell lines were established as described above.  
 
The pCMV-ECFP-Geminin construct was generated by PCR amplification of the 
sequence coding for the 110 amino acid N-terminus of Geminin from genomic DNA 
isolated from human cells. The PCR product was combined with the CMV promoter and 
CFP tag in a lentiviral vector harboring a hygromycin resistance cassette by Multisite 
Gateway cloning (Invitrogen). This plasmid was transfected into 293T cells to generate 
replication-defective viral particles using standard protocols, which were used to stably 
infect our engineered U2OS cell line. 
 
In silico mapping of cell cycle progression in individual cells 
We first established the average cell cycle duration of our cell line by imaging 
undamaged, freely cycling cells for 48h. During this time most cells underwent at least 
two successive divisions, which were identified from the Geminin-CFP reporter. The 
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time between successive divisions was measured and averaged for ~100 cells to establish 
the average cell cycle. For in silico mapping of cell cycle progression of individual cells 
at the time of damage, we imaged cells for 24h prior to addition of NCS (Figure S1B). 
This allowed most cells to divide at least once prior to damage; and we isolated 
trajectories where the time of division could be clearly determined. To relate elapsed time 
after division to cell cycle phase and progression, we measured the distribution of DNA 
content in an asynchronously growing culture by flow cytometry using propidium iodide 
staining. These distributions were fit using a modification of the Dean-Jett model (Dean 
and Jett, 1974) to determine the amount of cells in G1, S and G2 phases; and were 
subsequently translated to the time spent in various cell cycle phases using a previously 
published model (Toettcher et al., 2009). These durations were then mapped to the time 
since last cell division before damage was applied for individual cells to establish their 
cell cycle progression at the time of damage.  
 
Time-Lapse Microscopy 
24h prior to microscopy, cells were plated in RMPI lacking riboflavin and phenol red in 
poly-D-lysine coated glass-bottom plates (MatTek Corporation). The medium was 
supplemented with 10% fetal calf serum, 100 U/mL penicillin, 100 mg/mL streptomycin, 
250 ng/mL fungizone (Gemini Bio-Products) and 10 mM HEPES. Cells were imaged on 
a Nikon Eclipse Ti inverted microscope with a 40X plan apo objective (NA 0.95), 
Hamamatsu Orca ER camera and a Perfect Focus System. The microscope was 
surrounded by a custom enclosure to maintain constant temperature and atmosphere. The 
filter sets used were CFP - 436/20 nm; 455 nm; 480/40 nm (excitation; beam splitter; 
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emission filter), YFP - 500/20 nm; 515 nm; 535/30 nm; and mCherry - 560/40 nm; 585 
nm; 630/75 nm (Chroma). Images were acquired every 20 mins in the phase and CFP 
channels and every 60 mins in the YFP and mCherry channels. We acquired 6 z-sections 
with a step size of 0.75 µm in the YFP and mCherry channels. Image acquisition was 
controlled by MetaMorph software (Molecular Devices).  
	  
Image Analysis 
Image analysis was done by Matlab (MathWorks) based custom written software. Cell 
boundaries were calculated by two complementary approaches. (i) Cells were separated 
from background by thresholding a Top-Hat transform of the original image. Top-Hat 
transformation was used to remove trends that are spatially wider than cell diameters. (ii) 
Boundaries between adjacent, touching cells were identified by seed based 
watershedding. Seeds were calculated as the regional maxima of the Gaussian smoothed 
image. To eliminate bias to regional maxima by bright foci, images were first pre-
processed by morphological closing with a structure smaller than cell diameter but larger 
than foci. Foci were identified by taking advantage of their small size. Images were first 
transformed with Top-Hat to remove all intensities that are spatially larger that 10% of 
cell diameter. This transformation resulted in an image with a strongly intensified foci 
signal. Foci were then segmented by regional thresholding followed by seed-based 
watershedding (Figure 2.8). Similar to cell boundaries, seeds were calculated as the  
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Figure 2.8: Examples of automated foci segmentation 
 
Examples of automated foci segmentation in three cells with different 53BP1-YFP (A) or Rad52-
mCherry (B) foci numbers and intensities. Image processing was performed using the Ensemble 
Thresher software package developed in our lab. See experimental procedures for algorithmic details. 	  	  	  	  
	  
 
regional maxima of the fluorescence intensity. The image analysis algorithm was 
separately optimized to identify 53BP1-YFP foci and Rad52-mCherry foci, which 
differed in size and intensity. 
	  
Immunofluorescence  
Cells were grown on number 1.5 glass coverslips coated with poly-L-lysine (Sigma-
Aldrich). They were fixed with 2% paraformaldehyde, permeabilized with 0.2% 
Triton/PBS and blocked with 5% goat serum supplemented with 1% bovine serum 
albumin. Cells were treated with primary antibody to detect γ-H2AX (mouse 
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monoclonal JBW301, Upstate, 1:700 dilution) or BRCA1 (mouse monoclonal D-9, 
Santa Cruz, 1:100 dilution), washed and treated with secondary antibody conjugated 
with Alexa Fluor 647 (Molecular Probes). After washing, cells were stained with 
Hoechst (Molecular Probes) and embedded in Prolong Antifade (Invitrogen). 
Immunofluorescence preparations were imaged on the microscope described for live 
cell imaging and automated segmentation was performed in Matlab (MathWorks) 
with algorithms from CellProfiler (Carpenter et al., 2006). 	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Abstract 
 
The tumor suppressor p53 is activated by DNA DSBs and initiates transcriptional 
programs that promote repair, cell cycle arrest or terminal cell fates. The threshold of 
damage required for p53 activation is unclear. Using fluorescent reporters to quantify 
DSBs and p53 in single cells, we show that there is no distinct number of breaks above 
which all damaged cells induce p53 accumulation. The amount of DNA damage rather 
determines the probability of a p53 response. The decision to activate p53 is influenced 
by other cell-specific factors in addition to the number of DSBs. We also present 
evidence that the rates of DSB repair do not affect the probability of activating p53 or its 
dynamical behavior in response to DNA damage. 
 
Introduction 
 
The tumor suppressor p53 mediates the cellular response to DNA damage by triggering 
DNA repair and cell cycle arrest or by evoking cellular senescence and apoptosis. These 
functions of p53 are essential for preserving genomic integrity and preventing neoplastic 
transformation, and loss of p53 activity either by functional inactivation of its pathway or 
by gene mutation is a frequent event in the onset and progression of many human 
malignancies (Jin and Levine, 2001; Levine, 1997). p53 function is also critical to the 
efficacy of cancer therapies that generate DNA lesions, such as radiation and 
chemotherapy, and defects in p53 are often associated with therapy resistance (Jiang et 
al., 2009; Vousden and Lane, 2007). In order to gain a full appreciation of how p53 
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potentiates genomic stability, as well as to enable its clinical manipulation for maximal 
therapeutic benefit, it is essential to determine the sensitivity of the p53 pathway to 
various DNA lesions and identify factors that regulate its activation in response to 
genotoxic insult. 
 
Within cells, levels of p53 are tightly controlled by several autoregulatory feedback loops 
that direct the stability and degradation of its protein. Noteworthy in this regard, is the 
interaction between p53 and its negative regulator, the E3 ubiquitin ligase Mdm2. p53 
transcriptionally activates Mdm2 expression and Mdm2 targets p53 for degradation 
(Barak et al., 1993; Haupt et al., 1997; Kubbutat et al., 1997; Wu et al., 1993). This 
interaction keeps p53 levels low under unstressed conditions. In response to cellular 
stress such as DNA damage, p53 is activated through upstream mediators that induce 
post-translational modifications that disrupt the p53-Mdm2 interaction and allow p53 to 
stably accumulate in the nucleus. In particular, DNA DSBs induce rapid phosphorylation 
and activation of the ataxia-telangiectasia mutated (ATM) and checkpoint kinase 2 
(Chk2) kinases (Ahn et al., 2000; Bakkenist and Kastan, 2003; Matsuoka et al., 2000). 
Activated ATM and Chk2 subsequently phosphorylate and stabilize p53, which shows a 
series of highly regulated, undamped pulses in single cells. The amplitude and duration of 
p53 pulses is independent of the damage dose, whereas the number of pulses increases 
with higher damage (Lahav et al., 2004). In addition, these pulses are generated in an 
excitable manner, where both a transient or sustained input triggers a complete p53 pulse 
(Batchelor et al., 2008; Loewer et al., 2010). Remarkably, identical cells in a uniformly 
damaged population exhibit a large heterogeneity in their p53 response. A fraction of 
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cells do not activate p53, while other cells induce one or more p53 pulses (Lahav et al., 
2004). It is likely that this variation arises from differences in the cells’ number of breaks 
and rates of repair, and p53 may only be active in cells where the damage exceeds a 
threshold number of DSBs. 
 
Although much insight has been gained into the molecular mechanisms that regulate p53 
pulses in response to DNA DSBs, little is known about the threshold of damage 
necessary for p53 activation. Immunoblots for ATM and Chk2 phosphorylation in 
irradiated cells suggested that these kinases are activated in a highly sensitive manner. 
Damage doses estimated to generate one or two DSBs were sufficient for a partial 
activation of ATM, and doses that generated less than twenty DSBs evoked a complete 
ATM and Chk2 response (Bakkenist and Kastan, 2003; Buscemi et al., 2004). However, 
since these measurements averaged over a population of cells, it is unclear if all irradiated 
cells uniformly activated ATM, or, if the partial activation of ATM resulted from 
averaging between distinct subpopulations that either received a high number of breaks 
and generated a full ATM response or received no or few breaks and did not respond. 
Other measurements of the sensitivity of the p53 pathway were obtained by introducing 
restriction enzymes or linearized double-stranded DNA molecules into cells that were 
subsequently assayed for p53 function. Based on serial dilutions of the introduced 
substrates, it was estimated that a solitary DSB might suffice to activate a p53 response 
(Huang et al., 1996; Wahl et al., 1997). However, these estimates were limited by the 
lack of a direct observation of the number of DSBs in each cell, which raises the 
possibility that not all cells received exactly one DSB or uniformly activated a p53 
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response. In order to gain a clear quantitative understanding of the relationship between 
the number of DSBs, their rates of repair and p53 activation, it is therefore necessary to 
observe these events in the same living cell. 
 
In this study we quantify the number of DSBs and the induction of a p53 response in 
individual living cells by using fluorescent reporters. We show that the probability of 
inducing a p53 pulse increases with the amount of damage. However, there is no fixed 
threshold number of DSBs above which all cells trigger a p53 response. We demonstrate 
that a cell’s decision to activate a p53 pulse, as well as the dynamical properties of the 
pulse, are independent of the rates of DSB repair. Our findings suggest that in addition to 
the number of DSBs, other cellular factors potentially influence the activation of p53 in 
response to DNA damage. 
 
 Results 
 
4. Quantifying DNA DSBs and rates of repair in individual living cells 
 
We quantify DNA DSBs in single cells using a fluorescent reporter expressing mouse 
53BP1 fused to mCherry (Figure 3.1A). 53BP1 is a mediator protein in the DNA damage 
response. It localizes to chromatin regions adjacent to the break within minutes after 
damage, and forms discernable foci that serve as markers for the number and location of 
DSBs (Anderson et al., 2001; Bekker-Jensen et al., 2005; Jullien et al., 2002; Schultz et 
al., 2000). We established a clonal MCF7 breast carcinoma cell line that stably expressed  
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Figure 3.1 Experimental system for quantifying DNA DSBs in single, living cells 	  
(A) Schematic drawing of the 53BP1 reporter. (B) Cells expressing 53BP1- mCherry were fixed and 
stained with anti γ-H2AX antibody 30 mins after 5Gy γ-irradiation. The overlaid image, and the 
measured intensities of both 53BP1-mCherry and γ-H2AX staining across a random line in the 
nucleus (C) show co-localization between 53BP1 and γ-H2AX foci. (D) Time-lapse images of two 
cells expressing 53BP1- mCherry after 5Gy γ-irradiation. Images are maximum projections of z-stacks 
through the nucleus (see Experimental Procedures) in the mCherry channel. (E) Example of the 
automated segmentation for the enumeration of 53BP1-mCherry foci in a cell. Images are pseudo 
colored to improve visualization and segmented foci are shown in red. Image processing was 
performed using custom written Matlab based software (see Experimental Procedures for algorithmic 
details). (F) Enumerated 53BP1-mCherry foci (dots) and the exponential fits to the raw data (dashed 
lines) for the two cells shown in (C). (G) Time-lapse images of two cells that were pre-treated with a 
small molecule inhibitor of DNA-PK prior to 10 Gy γ-irradiation. The images show that foci decay 
more slowly when repair is inhibited. (H) The average half-life of 53BP1 foci after 10Gy γ-irradiation 
in a control population and in cells that were pre-treated with a small molecule inhibitor of DNA-PK. 
Half-lives were calculated by fitting a single exponential decay to the enumerated 53BP1-mCherry 
foci in individual cells. Bars represent mean + sd for a population of 97 cells in the 10 Gy control and 
81 cells in the 10 Gy + Inhibitor treatment (I) Distributions of the number of 53BP1-mCherry foci at 
18hr post damage in cells imaged every hour for 18hr (i) or imaged only once at 18hr (ii) post 
damage. No of cells = ~140 for each condition. (J) Average number of 53BP1 foci in cells treated 
with 0Gy, 5Gy and 10Gy γ-irradiation at 1hr post irradiation. Bars represent mean + sd. No of cells, n 
= 89 (0Gy IR), 97 (5Gy IR) and 65 (10Gy IR). (K) Distribution of the initial number and half-life (L) 
of 53BP1 foci in a population of cells treated with 5 Gy γ-irradiation.  
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Figure 3.1 (continued) 
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the 53BP1 reporter, and verified that foci formed by the tagged mouse 53BP1 proteins 
co-localize with the canonical marker for DSBs, γ-H2AX (Figure 3.1B, C). Our analysis 
showed that the number of 53BP1-mCherry foci in a cell decreases with time (Figure 
3.1D-F). We calculated the half-life of foci by fitting the enumerated foci with an 
exponential model. To confirm that the decay in the number of foci represents repair (and 
not loss of signal due to photobleaching), we treated cells with a specific small molecule 
inhibitor of DNA-PK (NU7026) and showed that their disappearance slows (Figure 3.1G, 
H). Additionally, we showed that the distribution of the number of foci at 18hr post 
irradiation is similar between cells that were imaged frequently (every hr) and cells that 
were imaged only at 18hr post irradiation (Figure 3.1I, p-value 0.41, Kolmogorov-
Smirnov test).  
 
We first characterized how individual cells in an irradiated population develop and repair 
DSBs. As expected, we find that the initial number of 53BP1 foci formed in cells 
immediately after damage increases with the irradiation dose (Figure 3.1J). Individual 
cells in a uniformly irradiated population acquire different initial numbers of 53BP1 foci 
and also vary in their kinetics of repair (Figure 3.1K, L). This shows that there is a large 
heterogeneity in the response of identical cells exposed to the same damage dose.  
 
2.  Is there a threshold number of DSBs required for p53 activation?  
  
Next, we investigated if there is a threshold number of DSBs required to initiate a p53 
pulse in damaged cells. To quantify p53 levels in single cells, we added a fluorescent  
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Figure 3.2: Quantifying the threshold number of DSBs required to activate a p53 pulse 
 
(A) Schematic drawing of the 53BP1 and p53 and H2B reporters. (B) Time-lapse images of MCF7 
cells expressing the reporters in (A) after damage (50 ng/ml NCS). The 53BP1- mCherry images are 
maximum projections of z-stacks through the nucleus (see Experimental Procedures). (C) 
Quantification of the number of 53BP1-mCherry foci (red) and the normalized average nuclear p53-
Venus intensity (green) for the cell shown in (B). (D) Distribution of the initial numbers of 53BP1 foci 
in cells that show a p53 pulse (pink) or do not pulse (blue) after damage. Cells were damaged with a 
range of NCS concentrations (12.5 ng/ml – 100 ng/ml) to generate a wide distribution of the number 
of DSBs. Number of cells = ~ 360. (E) The probability of inducing a p53 pulse after damage is plotted 
for cells binned according to their initial number of 53BP1 foci after damage. Bins were calculated 
with a bin size W = 2 foci and the probability of pulsing is calculated as the fraction of cells that show 
a pulse in each bin (blue dots). The blue line shows a robust, regression fit to all datapoints. Number 
of cells = ~ 360.  
 
 
 
 
 
 
reporter of p53 (p53-Venus) to cells expressing the 53BP1 reporter (Figure 3.2A-C). Our 
p53-Venus reporter has been previously described (Batchelor et al., 2008; Loewer et al., 
2010).  In addition, we added a fluorescent reporter for histone H2B (H2B-CFP) to obtain 
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a uniform nuclear signal that aided the automated segmentation of nuclei for image 
analysis.  
 
We treated cells expressing the triple reporters with a range of damage doses to generate 
a wide distribution of initial numbers of DSBs. To induce DSBs, we used the 
radiomimetic drug neocarzinostatin (NCS), instead of irradiating cells because this 
allowed us to add the drug directly to cells on the microscope and quantify DSBs before 
and immediately after damage without a significant time delay in image acquisition. We 
have previously shown that the kinetics of DSB repair following NCS treatment are 
similar to those in irradiated cells (Karanam et al., 2012). We found that the distributions 
of the initial numbers of DSBs for cells that do not pulse and cells that show a p53 pulse 
immediately after damage differed significantly (p-value 1.19x10-05,	   Kolmogorov-
Smirnov test, Figure 3.2D). However, there was still a large overlap between these 
distributions, indicating that there is no distinct threshold number of DSBs, below which 
cells do not activate p53 and above which all damaged cells uniformly generate a p53 
pulse. We observed that a higher percentage of cells in the non-pulsing population 
exhibited low numbers of DSBs compared to cells that induced a p53 pulse. To 
investigate this further, we binned damaged cells according to their number of DSBs and 
plotted the probability of inducing a p53 pulse (calculated as the fraction of cells that 
pulse) for each bin (Figure 3.2E). A linear relationship was observed; with the probability 
of activating a p53 pulse increasing with the number of DSBs. Our results indicate that a 
cell’s decision to activate p53 after damage is weighted by the number of DSBs, 
however, other factors potentially influence this decision. 
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4. Is the decision to activate a p53 pulse stochastic or controlled by cell-specific factors?  
 
Based on the observation that only a fraction of cells in a population with a similar 
number of DSBs activate a p53 response (for example, only ~50% of cells with ~20 
DSBs exhibit a p53 pulse, Figure 3.2E), we speculated that the induction of pulses might 
either be stochastic, or be influenced by other internal cellular factors such as the cell 
cycle phase or the status of the repair pathways or p53 network in a cell. To distinguish 
between these two possibilities, we treated cells with an initial low dose of damage and 
allowed them time to recover from this treatment. We then re-damaged cells with the 
same damage dose (Figure 3.3A). If p53 pulses are generated in a stochastic manner, we 
expect a cell’s response to the second treatment to be independent of its response to the 
first damage insult. Therefore, the population of cells that pulse in response to the second 
treatment should not be biased in how they responded to the first damage dose. We found 
that on average, 85% of the cells that pulsed in response to the second damage treatment 
had also activated a p53 pulse in response to the first damage dose (Figure 3.3B). This 
suggests that the generation of a p53 pulse in response to a distinct number of DSBs is 
not entirely stochastic but is potentially influenced by other internal cellular factors.   
 
3. How do the rates of DSB repair affect the p53 response? 
 
One potential factor that may affect a cell’s decision to pulse after damage is the activity 
of its DNA repair machinery, which is reflected in its kinetics of repair. Cells that achieve 
rapid recognition and repair of DSBs may not initiate a p53 pulse in response to damage, 
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Figure 3.3: Activation of p53 in response to DNA DSBs is influenced by internal cellular factors 
(A) Schematic representation of the experimental design to investigate if the decision to activate a p53 
pulse is stochastic or determined by cell-specific factors. Cells were damaged with a low dose of NCS 
and analyzed for the activation of a p53 pulse. The same cells were re-damaged with the same dose of 
NCS 6h after the first damage treatment, and assessed for the induction of a p53 pulse in response to 
the second damage treatment. (B) The percentage of cells in a population that induced a p53 pulse in 
response to the second damage treatment, that had activated a p53 pulse (blue) or did not pulse (red) in 
response to the first damage treatment. Bars represent mean + sd.   
 
 
 	  
 
while cells that are slower in their response to DNA DSBs may activate p53 to induce 
cell-cycle arrest and allow additional time for repair. To test this hypothesis, we plotted 
the distributions of the half-lives of 53BP1 foci for cells categorized into two groups 
based on whether they pulse or do not pulse after damage (Figure 3.4A). We observed 
that the distributions were similar between the two groups (p-value 0.1071,	  Kolmogorov- 
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Figure 3.4: Quantifying the effect of the rates of DSB repair on the p53 response 
 
(A) Distribution of the half-life of 53BP1 foci for cells that show a p53 pulse (pink) or do not pulse 
(blue) after damage (12.5 ng/ml – 100 ng/ml NCS). Number of cells = ~ 360. (B) The probability of 
inducing a p53 pulse after damage is plotted for cells binned according to their half-life of 53BP1 foci 
after damage. Bins were calculated with a bin size W = 2 hours and the probability of pulsing is 
calculated as the fraction of cells that show a pulse in each bin (blue dots). The blue line shows a 
robust, regression fit to all datapoints. Number of cells = ~ 360. (C) The duration of the p53 pulse, 
calculated as the full-width at half-maximal amplitude is plotted against the initial number of 53BP1 
foci for a population of ~360 cells. (D) The amplitude of the p53 pulse, calculated from the 
normalized p53 trajectories is plotted against the initial number of 53BP1 foci for a population of 
~360 cells. In (C) and (D), the black line shows the least-squares fit to the datapoints. 	  
 
 
Smirnov test), suggesting that the rates of repair do not affect the decision to activate p53 
after damage. A plot of the probability of inducing a p53 pulse for cells binned according 
to their half-lives of DSBs further confirmed the lack of a significant correlation between 
the rates of repair and the probability of activating p53 post damage (Figure 3.4B). 
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While the rate of DSB repair does not affect the decision to activate p53 after damage, it 
might still influence the dynamical properties of the pulse, such as its period and 
amplitude, in cells that activate p53. To explore this, we plotted the duration of the p53 
pulse against the half-life of DSBs for individual cells (Figure 3.4C). No correlation was 
observed indicating that the rate of repair does not affect the period of the p53 pulse in 
damaged cells. Similarly, the amplitude of the p53 pulse did not correlate strongly with 
the rates of repair in individual cells, showing that the levels of active p53 are also 
independent of the speed at which DSBs are repaired (Figure 3.4D).  
 
Intrigued by the above findings, we wondered if altering the rates of repair beyond the 
normal variance observed in a damaged population would affect the p53 dynamics in 
these cells. To generate a significant delay in the rates of DSB repair, we attempted to 
knock down XRCC4, a key protein in the nonhomologous end-joining pathway of DSB 
repair. XRCC4 in complex with DNA ligase IV functions in the final step of DSB repair 
where the processed DNA ends are ligated together to generate an intact molecule. We 
infected our reporter cell line with a virus expressing a shRNA specific for XRCC4, and 
found that this treatment was effective in reducing XRCC4 gene expression to 4% of its 
normal cellular level (Figure 3.5A). However, this knock down only resulted in an 
approximately 50% reduction in the XRCC4 protein level three days after infection 
(Figure 3.5B, C). Using immunofluorescence analysis, we verified that the 50% reduction 
in protein levels observed on the immunoblot resulted from a uniform knock down of 
XRCC4 in all cells of the infected population (Figure 3.5D).  
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Figure 3.5: Effect of reduced XRCC4 expression on the p53 response 
 
(A) Quantification of the level of XRCC4 mRNA expression in an untreated control (black) and in 
cells treated with a non-specific scramble shRNA (green) or specific XRCC4 shRNA (red). mRNA 
levels were measured by quantitative PCR. (B) Immunoblot of XRCC4 in an untreated control and in 
cells treated with scramble shRNA or XRCC4 shRNA. Cells were harvested on day 2 (D2) or day 3 
(D3) after treatment. (C) Protein quantification of the blot in (B) normalized to Actin and the control. 
(D) Untreated control and cells treated with XRCC4 shRNA were fixed on day 3 after treatment and 
immunostained to visualize XRCC4. Images show a uniform reduction in XRCC4 protein levels in all 
treated cells. Images are overlays of the phase channel and the Cy5 channel used for visualizing the 
staining. (E) The average half-life of 53BP1 foci after damage (100 ng/ml NCS) in a control 
population and in cells treated with XRCC4 shRNA. (F) Trajectories of normalized p53 levels after 
damage (100 ng/ml NCS) for three control cells (top row) and three cells treated with XRCC4 shRNA 
(bottom row). (G) Average amplitude of the p53 pulse after damage (100 ng/ml NCS) for control cells 
and cells treated with XRCC4 shRNA. (H) Average duration of the p53 pulse after damage (100 
ng/ml NCS) for control cells and cells treated with XRCC4 shRNA. The duration of the pulse was 
calculated as the full-width at half-maximal amplitude. In (E) – (H), cells were damaged on day 3 after 
treatment with XRCC4 shRNA. Bars represent mean + SEM for a population n=130 for knock down 
cells and n=180 for controls. 
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We damaged cells treated with the XRCC4 shRNA and analyzed their rates of DSB 
joining. We found that a 50% reduction in XRCC4 protein levels did not generate a delay  
in DSB repair. Rather, we were surprised to find that the half-life of 53BP1 foci was 
shorter, indicating faster repair, in the knock down cells compared to normal controls 
(Figure 3.5E). At present we cannot explain why a reduction in XRCC4 protein levels 
increases the rates of DSB repair.  
 
We analyzed how the reduced XRCC4 expression affects the dynamical properties of the 
p53 pulse in response to DNA DSBs. We found no difference in the amplitude of the p53 
pulse between cells treated with the XRCC4 shRNA and normal controls (Figure 3.5F, 
G). However, the duration of the p53 pulse significantly increased in the knock down 
cells compared to normal controls (Figure 3.5F, H, p-value 0.007, t-test). The wider p53 
pulses observed in the knock down cells are qualitatively similar to those observed in 
response to UV treatment, where p53 is primarily activated by the upstream kinase ATR 
(Ataxia telangiectasia and Rad3 related). We hypothesize that abatement of XRCC4 
protein levels might prevent the effective ligation of a few DSBs in damaged cells. A 
failure to ligate DNA ends potentially promotes an increased resection of DNA at these 
break sites in an attempt to improve the annealing between the DNA strands and promote 
re-ligation. The resected ssDNA strands may then recruit and activate ATR, which 
subsequently modifies p53 and increases the duration of its pulse. Future work employing 
specific ATR inhibitors will aid the investigation of this hypothesis. 
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Future studies also comprise an investigation of other methods to perturb the kinetics of 
DSB repair to determine if altering the rates of repair affects the decision to induce p53, 
as well as its dynamic behavior after DNA damage. This includes knocking down other 
DNA repair proteins such as Ku70/80 or DNA Ligase IV in the NHEJ pathway or 
BRCA1, BRCA2 or Rad51 in the HR pathway by using shRNA against these proteins or 
inhibiting their activity by using specific small molecular inhibitors. Future work also 
includes an exploration of other factors that influence the activation of p53 in response to 
DSBs. One potential factor that may affect a cell’s decision to pulse is its cell cycle 
phase. Previous work from our group has demonstrated that cells show spontaneous 
pulses of p53 in basal, undamaged conditions. These pulses occur in cell cycle phases 
that are associated with low levels of intrinsic DNA damage. It is possible that 
spontaneous p53 pulses are followed by a refractory period during which a cell is unable 
to initiate a new pulse even if it is damaged. Observations of cells for several hours prior 
to damage to obtain their cell cycle stage and p53 history will determine if any of these 
potential factors influence p53 activation.  
 
Furthermore, it is possible that the p53 response to DNA DSBs is highly deregulated in 
cancer cells such as the MCF7 cells we used in this study. It will be important to establish 
our fluorescent reporter system in primary cells or in a non-transformed cell line such as 
the MCF10A breast epithelial cell line to investigate if normal cells are more uniform in 
their response to DNA damage. Similar investigations carried out in multiple tumor cell 
lines will determine how different cancers activate p53 in response to DNA DSBs. 
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Experimental procedures 
 
Cell culture 
Human breast cancer epithelial MCF7 cells were grown in RPMI 1640 medium 
supplemented with 10% fetal calf serum, 100 U/mL penicillin, 100 µg/mL streptomycin 
and 250 ng/mL fungizone (Gemini Bio-Products). When required, the medium was 
supplemented with selective antibiotics (400 µg/mL G418, 5 µg/mL blasticidin, 50 
µg/mL hygromycin). When indicated, medium was replaced with fresh medium 
supplemented with Neocarzinostatin (National Cancer Institute) or with the DNA-PK 
inhibitor NU7026 (used at 10 µM, Sigma) during experiments. Irradiation treatments 
were carried out in a 60Co irradiator. 
 
Cell Line Construction 
The original pCMV-EGFP-53BP1 construct was kindly provided by Prof. Yasuhisa 
Adachi (Jullien et al., 2002). We generated our pEF1α-mCherry-53BP1 plasmid by 
replacing GFP with mCherry and combining this fluorescent protein-cDNA fragment 
with the EF1α promoter in a vector harboring a blasticidin resistance cassette using 
standard molecular biology techniques. This plasmid was stably transfected into MCF7 
cells using FuGENE6 (Roche), which were maintained in selective media and sorted into 
single cells using fluorescence activated cell sorting to generate a clonal population. Our 
pMT-p53-Venus plasmid has been previously reported (Batchelor et al., 2008). Stable, 
clonal cell lines were established as described above.  
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For constructing the pUbC-H2B-CFP vector, the H2B coding sequence was amplified by 
PCR from the vector pBOS-H2BGFP (BD Bioscience). Using Multiside Gateway 
technology (Invitrogen), the PCR product was combined with the UbC promoter and CFP 
tag in a lentiviral vector harboring a hygromycin resistance cassette. This plasmid was 
transfected into 293T cells together with the corresponding packaging plasmids to 
generate replication-defective viral particles using standard protocols, which were used to 
stably infect the engineered MCF7 cell line. 
 
To generate XRCC4 knock-down cells, XRCC4 shRNA (TRCN40114) was obtained 
from OpenBiosystems. Lentiviral particles expressing XRCC4 shRNA or non-specific 
scramble shRNA (TRCN130036) were produced in 293T cells. MCF7 cells expressing 
all three reporters (53BP1-mCherry, p53-Venus and H2B-CFP) were infected with 1 ml 
of cell supernatant collected from the 293T cells.  
 
Analysis of gene expression 
Cells were harvested and total RNA was extracted using the RNeasy protocol (Qiagen). 
RNA concentrations were quantified by measuring absorbance at 260 nm. Equal RNA 
levels were used to generate complementary DNA using the high-capacity cDNA reverse 
transcription protocol (Applied Biosystems). Quantitative PCR was then performed using 
reaction mixtures of 8.4 ng total RNA, 100 nM primer (XRCC4 forward: CTG AAA 
TGA CTG CTG ACC GAG ATC C; XRCC4 reverse: TTA CAG CAG CTG AAG CCA 
ACC CAG AG; GAPDH forward: CAT GTT CGT CAT GGG TGT GAA CCA; 
GAPDH reverse: AGT GAT GGC ATG GAC TGT GGT CAT), and SYBR Green 
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reagent (Applied Biosystems). Reactions were set up in triplicate and run on a iCycler iQ 
PCR machine (BioRad). 
  
Western Blot Analysis 
Harvested cells were lysed in the presence of protease and deacetylase inhibitors. Total 
protein levels were quantified using the BCA assay (Pierce). Equal protein amounts were 
separated by electrophoreses on a 4%–12% Bis-Tris gradient gel (Invitrogen) and 
transferred to a PVDF membrane by electroblotting. The membrane was blocked with 
5% nonfat dried milk and incubated overnight with primary antibody (anti-XRCC4 rabbit 
polyclonal, Abcam ab145, 1:1000 dilution). The membrane was washed and incubated 
with secondary antibody coupled to peroxidase, and protein levels were detected with 
chemoluminiscence (ECL plus, Amersham) after additional washing steps. XRCC4 
levels were quantified by normalizing to total β-actin (Sigma). 
 
Time-Lapse Microscopy 
24h prior to microscopy, cells were plated in RMPI lacking riboflavin and phenol red in 
poly-D-lysine coated glass-bottom plates (MatTek Corporation). The medium was 
supplemented with 10% fetal calf serum, 100 U/mL penicillin, 100 µg/mL streptomycin, 
250 ng/mL fungizone (Gemini Bio-Products) and 10 mM HEPES. Cells were imaged on 
a Nikon Eclipse Ti inverted microscope with a Plan Apo 60X oil objective (NA 1.4), 
Hamamatsu Orca ER camera and a Perfect Focus System. The microscope was 
surrounded by a custom enclosure to maintain constant temperature and atmosphere. The 
filter sets used were CFP - 436/20 nm; 455 nm; 480/40 nm (excitation; beam splitter; 
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emission filter), YFP - 500/20 nm; 515 nm; 535/30 nm; and mCherry - 560/40 nm; 585 
nm; 630/75 nm (Chroma). Images were acquired every 15 mins in the phase, YFP and 
CFP channels and every 30 mins in mCherry channel for 8-12 hrs. We acquired 7 z-
sections with a step size of 1 µm in the mCherry channel. Image acquisition was 
controlled by MetaMorph software (Molecular Devices).  
 
Image Analysis 
53BP1 foci were analyzed using custom written algorithms in Matlab (Mathworks). In 
brief, image stacks were first enhanced using blind deconvolution (AutoQuant), and were 
then converted to 2D maximum projections. Nuclei were segmented the H2B-CFP signal. 
For each nucleus, the background signal was first reduced by a Tophat transformation, 
following which the edges were detected using the Canny method. Foci were determined 
from the edges using morphological transformations and thresholding. Touching foci 
were then separated by a marker-directed watershed algorithm. We analyzed p53 
trajectories in single cells using previously described algorithms (Loewer et al., 2010). 
 
Immunofluorescence 
Cells were grown on number 1.5 glass coverslips coated with poly-L-lysine (Sigma-
Aldrich). They were fixed with 2% paraformaldehyde, permeabilized with 0.2% 
Triton/PBS and blocked with 5% goat serum supplemented with 1% bovine serum 
albumin. Cells were treated with primary antibody to detect γ-H2AX (mouse 
monoclonal JBW301, Upstate, 1:700 dilution) or XRCC4 (rabbit polyclonal ab145, 
Abcam, 1:500 dilution), washed and treated with secondary antibody conjugated with 
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Alexa Fluor 647 (Molecular Probes). After washing, cells were stained with Hoechst 
(Molecular Probes) and embedded in Prolong Antifade (Invitrogen). 
Immunofluorescence preparations were imaged on the microscope described for live 
cell imaging and automated segmentation was performed in Matlab (MathWorks) 
with algorithms from CellProfiler (Carpenter et al., 2006). 
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Chapter 4: Discussion and Future Perspectives 
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Defective DNA repair is both the origin and the weakness of many cancer cells. Several 
tumors arise from a perturbed DNA damage response that generates mutations in genes 
that regulate cell growth and division. Tumor cells also depend on DNA repair to survive 
cancer treatments that induce DNA DSBs, such as radiation and chemotherapy. Their 
reduced repair capacity makes them particularly sensitive to inhibition of the remaining 
repair proteins, offering the possibility that using DNA repair inhibitors in combination 
with treatments that generate DNA damage or trap cells in states with an increased 
requirement for specific repair pathways, will be more effective in removing tumors with 
minimal toxicity to the surrounding healthy cells. In order to exploit this inherent 
vulnerability of cancer cells effectively, it is first necessary to develop a comprehensive 
understanding of the coordinated behavior of the alternate DSB repair pathways and their 
ability to compensate for each other in different basal conditions and cellular 
circumstances. DNA repair is also intimately interconnected with pathways that regulate 
cell fate decisions such as cell cycle arrest, senescence or cell death. Knowledge of how 
DNA repair synergizes with the activation of cell fate regulators for the execution of 
specific cellular outcomes is vital to gain a full appreciation of the processes that prevent 
transformation and for the intelligent design of cancer therapies.  
 
My research focused on developing a detailed, quantitative understanding of how the 
kinetics of repair and the balance between the alternate DSB repair pathways changes 
with cell cycle, and on characterizing the relationship between DSBs, repair, and the 
activation of the tumor suppressor p53 in human cells. DNA repair and the activation of 
cell fate regulators in response to damage are inherently dynamic processes and time 
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separated events; hence to precisely characterize the relationship between them as well as 
connect their behavior with cell state prior to damage, it is necessary to follow these 
events over time in the same cell. We therefore developed fluorescent reporters to 
quantify DSBs, HR, cell cycle and p53 accumulation in individual, living cells. 
 
We first established a cell line that stably expressed our DSB, HR and cell cycle reporters 
and determined how the rates of repair and the activation of HR change throughout the 
cell cycle. We found that the kinetics of DSB repair vary with cell cycle phase at the time 
of damage. We measured the balance between NHEJ and HR in unperturbed, wild type 
cells and showed that NHEJ is the dominant repair pathway in G1 and in G2 phase when 
HR is functional. We found that S and G2 cells use both NHEJ and HR for repair and 
higher use of HR correlates with slower repair. Further, we demonstrated that the balance 
between NHEJ and HR changes gradually as cells enter or exit S phase and maximal use 
of HR occurs in mid-S at the peak of DNA replication. Our data therefore suggests that 
the level of active DNA replication influences the use of HR in human cells. To further 
consolidate this finding, it is essential to disentangle the effect of cyclin activity and the 
presence of replicating DNA on the choice of repair. No perturbation is currently known 
to affect one and not the other in mammalian cells, hence, a definitive conclusion will 
first require the identification and characterization of new perturbations that prohibit 
DNA replication but allow cells to progress through S phase. One potential perturbation 
is to knock down or inhibit essential proteins of the pre-replication complexes that 
regulate the firing of replication origins. Cdc7, Dbf4 and the Mcm proteins are some 
candidates that can be explored for this perturbation.  
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Additionally, future studies also include knocking down or inhibiting various repair 
proteins in both DSB repair pathways to investigate how perturbing the pathways affects 
the balance between them. Such analyses will provide insights into the ability of the two 
repair pathways to compensate for each other under altered conditions of repair. It is 
likely that inhibition of some repair proteins will lead to an increased use of the alternate 
DSB repair pathway, while knocking down other proteins may prevent DSB joining by 
both repair pathways. For example, knocking down CtIP or BRCA1 that function in the 
DNA resection step of the HR pathway may allow an increased processing of DSBs by 
NHEJ, while knocking down HR proteins that function after DNA resection (for example 
Rad51, BRCA2) may prevent DSB joining by both HR and NHEJ. Similar measurements 
of the balance between NHEJ and HR in multiple cancer cell lines that lack different 
repair proteins, as well as in normal cells, are critical for understanding the coordinated 
behavior of the repair pathways in different tissues and cellular contexts. Further, many 
cancer cells also have disabled checkpoints; for example, the U2OS cells we used in our 
study lack a stable G1/S arrest. This allows damaged G1 cells to enter S phase and 
activate HR for repair. It will be important to determine how tumors with different 
checkpoint profiles activate and balance NHEJ and HR and to compare their behavior 
with non-transformed cells. Collectively, such analyses will enable the design of more 
selective and efficacious cancer treatments.  
 
In our study, we imaged cells at hourly intervals post DNA damage. This provided 
snapshots of the total numbers of DSBs over time in each cell; however, it did not allow 
tracking individual foci between time points. Development of techniques that permit 
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tracking discrete foci will enable observations of individual repair events over time in the 
same cell. Such observations are essential to determine if individual breaks in a cell 
switch between the two repair pathways during the course of repair and the timing when 
this occurs. They will also enable an investigation of the possibility that S phase cells 
repair more slowly due to new damages being created in this phase during DNA 
replication.   
 
Next, we explored the connection between the number and repair of DNA DSBs and the 
activation of the tumor suppressor p53. We combined our reporter for DSBs with the 
fluorescent reporter for p53 to quantify the level of damage and the activation of p53 in 
the same, living cell. We showed that there is a linear correlation between the number of 
DSBs and the probability of activating a p53 pulse. However, there is no clear threshold 
of damage above which all damaged cells unanimously induce a p53 response. We found 
that the decision to activate a p53 pulse is potentially influenced by cell-specific factors. 
Further, we eliminate the rates of DSB repair as a factor that affects this decision. We 
also demonstrated that the dynamical properties of the p53 pulse are independent of the 
speed with which breaks are repaired. Remarkably, perturbing the NHEJ repair pathway 
by reducing XRCC4 protein levels did not decrease the rates of DSB repair. However, 
this perturbation increased the duration of the p53 pulse. Future studies comprise 
knocking down or inhibiting additional repair proteins in both pathways by using shRNA 
or small molecule inhibitors, in order to generate a longer delay in the rates of DSB 
repair. This will allow measurements of how altering the kinetics of repair beyond the 
normal variation observed in a damaged population affects the decision to activate p53 in 
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response to DNA damage. Perturbations to different repair proteins will also determine if 
the alteration in p53 dynamics occur exclusively in response to abatement of XRCC4 
levels. Recent work from our group has shown that the dynamical behavior of p53 in 
response to DSBs encodes critical cell-fate decisions; hence understanding how 
perturbations of key repair proteins alter the p53 response will provide new and important 
insights for the treatment of tumors with different genetic profiles and repair deficiencies.  
 
Future studies also include an exploration of other factors that potentially influence a 
cell’s decision to activate a p53 pulse in response to DNA DSBs. One potential factor is 
the expression level of key proteins of the p53 pathway such as wip1, mdm2 and p53 
itself. The stimulus provided by low numbers of DSBs may not be sufficient to initiate 
p53 accumulation in cells that express very low levels of p53 or high levels of its 
negative regulators wip1 or mdm2. Another factor that might affect a cell’s decision to 
activate a p53 pulse, is its cell cycle stage. Cells damaged in different cell cycle phases 
may differ in their threshold of DSBs required for p53 activation. Moreover, undamaged 
cells show spontaneous p53 pulses in cell cycle phases that are associated with low levels 
of intrinsic DNA damage. It is possible that these spontaneous pulses are followed by a 
refractory period during which a cell is unable to initiate a new pulse even if it is 
damaged. Observations of the cell cycle stage and p53 behavior of cells prior to damage 
will determine if any of these potential factors influence p53 activation.  
 
Our analyses showed that some cells do not activate p53 even at high levels of DNA 
damage. One possibility is that the induction of p53 in response to DSBs is highly 
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deregulated in cancer cells such as the MCF7 cells we used in our study. It will be 
important to determine if normal, non-transformed cells are more uniform in their p53 
response, and activate p53 at a low number of DSBs. Additionally, measurements of the 
number of DSBs and p53 activation in multiple cancer cell lines will enable an 
understanding of their potential to uniformly induce p53 in response to DNA damage, 
and will provide insights into their sensitivity to radiation and chemotherapeutic 
treatments. 
 
Finally, the use of fluorescent reporters to measure DNA damage responses in live cells, 
combined with the quantitative, single cell techniques developed in this work present 
powerful tools for addressing additional long-standing, fundamental questions in the 
DNA damage and repair field. For example, studies using reporters for different sub-
pathways of homology dependent repair can provide insights into their interplay and 
balance at different stages of repair. Similar analyses of different mediator and repair 
proteins will help determine the timing at which commitment to a specific repair pathway 
occurs and the factors leading to these decisions. Additionally, investigations combining 
reporters for repair and checkpoint regulators with indicators of cell fates will instruct us 
on how the rates and mechanisms of repair correlate with time through the checkpoints 
and with the execution of specific cellular outcomes. Such analyses afford an integrated, 
systems-level understanding of the complex interrelationships between the myriad 
signaling and repair pathways that comprise the DNA damage response in mammalian 
cells. 	  	  
